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Conjugated polymers are known to be a class of promising materials with 
excellent light harvesting properties. Fluorescent conjugated polymers have been 
emerging as a novel class promising materials in broad biological applications 
from sensing, imaging to diagnostics and therapy. For biological imaging and 
therapy, high spatial resolution (3-dimensional selectivity) and deep tissue 
penetration are of great scientific and practical importance. Two-photon excitation 
imaging and photodynamic therapy are promising noninvasive techniques for 
deep tissue imaging and cancer treatments with high spatial resolution. However, 
the lack of efficient biological two-photon fluorophores/photosensitizers limits the 
practical application of these techniques.  It would be of great scientific and 
practical importance to develop conjugated polymers for two-photon biomedical 
applications. In this thesis, various conjugated polymers and conjugated polymer 
nanoparticles have been synthesized and their one-photon and two-photon optical 
properties have been studied; and they have been developed for two-photon cell 
imaging and two-photon photodynamic therapy. 
Firstly, we designed and synthesized two new water-soluble conjugated 
polymers, acting as two-photon light harvesting complexes to amplify the two-
photon property of water-soluble photosensitizers and organic dyes through 
fluorescence resonance energy transfer. To study the ability of conjugated polymer 
for enhancing two-photon excitation singlet oxygen generation ability, which is 
critical for two-photon photodynamic therapy, we then developed photosensitizer-
doped conjugated polymer nanoparticles and demonstrated their two-photon 
enhanced singlet oxygen generation abilities. Following that, we demonstrated 
IX 
 
biocompatible conjugated polymer nanoparticles for potential simultaneous two-
photon imaging and two-photon photodynamic therapy in cell level.  
Furthermore, to explore conjugated polymers as direct photosensitizers for two-
photon photodynamic therapy applications, we designed and synthesized a series 
of conjugated polymers with different substitute group on the backbone. The one-
photon and two-photon optical properties of the conjugated polymers were studied. 
On the other hand, singlet oxygen generation ability of the conjugated polymers 
under one photon and two-photon excitation were evaluated. The polymers was 
successfully demonstrated for two-photon cell imaging and two-photon 
photodynamic therapy. 
Finally, we developed high efficient conjugated polymer nanophotosensitizers 
for cancer cell targeted two-photon photodynamic therapy. The novel 
nanophotosensitizers were found to display a significant enhancement the two-
photon emission and efficient two-photon induced singlet oxygen generation 
ability. The nanophotosensitizers were further functionalized with folate on the 
surface. One-photon and two-photon cell imaging show that the folate 
functionalized nanophotosensitizers shows highly specific targeting ability to 
folate acceptor overexpressing cancer cells. The enhanced folate acceptor targeted 
two-photon photodynamic therapy effect on cancer cells have been demonstrated.  
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Chapter 1  
Introduction 
 
1.1 Conjugated polymers 
1.1.1 Conjugated polymers 
During the past three decades, conjugated polymers (CPs) have attractive an 
intensive interest in laboratories around the globe for their broad applications in 
various fields, including organic light emitting diodes (OLED) for flat panel 
displays,1 photovoltaic devices for solar energy conversion,2 field-effect 
transistors (FET) and chemical sensors.3 Structurally, conjugated polymers are 
macromolecules that are composed of one-dimensional conjugated backbone with 
alternating C=C, and C-C bonds.4 The backbone structures of some common 
conjugated polymers are shown in Figure 1.1. Owing to the highly delocalized 
π-electron along the conjugated backbone, conjugated polymers have 
distinguished electronic and optical properties.5 The versatile electronic and 
optical properties of conjugated polymer can be fine-tuned through using different 
conjugated backbones and side chains, motivating scientists to explore their 















Figure 1.1 Some common conjugated polymers. 
 
1.1.2 Fluorescence of conjugated polymers 
The fluorescence of conjugated polymers can by illustrated by classic Jablonski 
diagram. As shown in a typical Jablonski diagram in Scheme 1.1, following light 
absorption, a conjugated polymer is usually excited to some higher vibrational 
lever of either S1 or S2. Generally, conjugated polymers rapidly relax to the lowest 
vibrational level of S1 via internal conversion and this process generally occurs 
within 10-12 s or less. Since fluorescence lifetimes are typically much shorter, 
internal conversion is generally complete prior to emission. The fluorescence 
lifetimes of conjugated polymers are from picoseconds to nanoseconds. Most of 
studies of conjugated polymers have focused on their fluorescence properties. 
In addition to fluorescence emission, polymers in the S1 state can also undergo 
a spin conversion to the first triplet state T1 via intersystem crossing. Emission 
from T1 is termed phosphorescence. As transition from T1 to S0 is forbidden, the 
rate constants of triplet emission are several order of magnitude smaller than those 
for fluorescence emission. The phosphorescence lifetimes are from microseconds 
to miniseconds. Molecules containing heavy atoms such as bromine and iodine are 
3 
 
frequently phosphorescent. Heavy atoms can facilitate intersystem crossing and 
thus enhance phosphorescence quantum yield.7 Room-temperature 
phosphorescence in conjugated polymers is rare. However, conjugated polymers 
can be directly excited to afford triplex excited states with moderate efficiency.8 
 
Scheme 1.1 A typical Jablonski diagram. S0: ground singlet state; S1: first excited 
state 1; S2: second excited singlet state 2; T1: excited triplet state 1. 
 
The absorption and emission features of conjugated polymers are highly 
associated with their polymer structures and conformations in solution of solid 
state. The main critical factors to determine their fluorescence properties include 
effective conjugation length of backbone, conjugated backbone structures, the 
molecular conformation and packing.9 First of all, the emission wavelength highly 
relies on the conjugated length of conjugated polymers. Increasing the conjugation 
length in general lowers the energy band gap of the polymers, leading to longer 
emission wavelength. The effective conjugation length has been determined to be 
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the polymeric segment length which generally containing 8 to 11 repeating units.10 
Molecularly, the fluorescence wavelength of conjugated polymers will not change 
further if the length of polymer chain exceeds beyond the effective conjugation 
length. Secondly, the emission wavelength can be fine-tuned by changing 
conjugated backbone structures. By introducing electron donor/acceptor repeating 
units into the backbone will leads to lower band gap of the polymers and red shift 
the emission. At last, the fluorescence wavelength and quantum yield conjugated 
polymers are also affected by the conformation, aggregation or packing structures 
of the polymers chains. 
 
1.1.3 Optical amplification properties of conjugated polymers 
The backbone of CPs serves to hold a series of conjugated segments in close 
proximity, with π-electrons delocalizing along the backbone. The delocalized 
electronic structure endows fluorescent CPs unique optical properties. Excitation 
energy of CPs can be efficiently transferred to lower electron/energy acceptor sites 
over long distances to super-quench the fluorescence of CPs or to amplify the 
signals of the acceptors via fluorescence resonance energy transfer (FRET). This 
feature is called super-quenching or optical amplification properties of CPs 
(Scheme 1.2).3,11,12 In analogy to microelectronic devices, the amplification is 
derived from a combination of delocalization of the electronic excited state and 




Scheme 1.2 Optical amplification scheme of conjugated polymers via 
fluorescence energy transfer 
 
The quenching processes in conjugated polymers can be analyzed by 
Stern-Volmer relationships: 
F0/F = 1 + Ksv[Q] 
where F0 is the fluorescence intensity in absences of quencher, F is the 
fluorescence intensity as a function of quencher concentration [Q]. The slope of 
the plots gives the Stern-Volmer quenching constant (Ksv). The use of fluorescent 
conjugated polymers can lead to a greater than million-fold amplification of the 
sensitivity (or Ksv) to fluorescence quenching, relative to that of corresponding 
small conjugated molecules with similar structures. 
  The quencher can be designed as an energy acceptor to allow for efficient 
fluorescence resonance energy transfer (FRET) for the conjugated polymer to the 
acceptor. FRET is a nonradiative process whereby an excited state donor transfers 
energy to a proximal ground state acceptor through long-range dipole-dipole 
interactions based on Förster theory.13 The rate of energy transfer is highly 
dependent on spectral overlap between the emission of the donor and absorption 
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of acceptor, the relative orientation of the transition dipoles, and most importantly, 
the distance between the donor and the acceptor molecules.   As shown in the 
equation, the FRET rate (kt) is a function of the donor-acceptor distance (r), the 
orientation factor (k) and the overlap integral (J).  
 
The energy transfer efficiency can be determined from either steady-state or 
time-resolved measurements. 
E = 1-FDA/FD 
E = 1-τDA/τD 
F is the relative fluorescence intensity of donor in absence (FD) and presence (FDA) 
of acceptor. Maximal optical overlap and a short distance between the donor and 
acceptor molecules will favor the FRET process and high energy transfer 
efficiency.  
FRET is very useful for bioanalysis because of its intrinsic sensitivity to 
nanoscale change in donor/acceptor separation distance (proportional to r6). It has 
been utilized in applications ranging from the assay of interactions of antigen with 
antibody in vitro to the real-time imaging of protein folding in vivo. 14,15 
The conjugated polymer donor and the acceptor can be chosen to meet the 
requirement of the spectral overlap between the emission of the conjugated 
polymer and the absorption of the acceptor.3 The unique characteristic of 
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conjugated polymers is their ability to amplify signal of dyes labeled on analytes 
so that lower concentration of analytes can be easily detected, in comparstion to 
directly excite the small molecular dyes.3,16,17 
 
1.1.4 Fluorescent conjugated polymers for biological applications 
The unique optical properties of conjugated polymers make them attractive for 
potential biological applications.18,19 Water solubility of conjugated polymers is 
essential for their biological application. Water soluble fluorescent conjugated 
polymers have been synthesized and studied for their applications in aqueous 
solution.20 Generally, they contain two parts: the hydrophobic conjugated 
backbone and hydrophilic side chains or ion charged groups (eg. ammonium, 
sulfonate) ensuring for the solubility in water.20 In addition to developing 
conjugated polymers with water soluble charged side chains, water dispersible 
conjugated polymer nanoparticles have also aroused researcher’s great attentions 
in recent years.21-25 Well stable and water dispersible conjugated polymer 
nanoparticles can be facilely prepared from hydrophobic conjugated polymers by 
reprecipitation method.22,25 In general, the hydrophobic conjugated polymers 
solution in a miscible solvent such as THF or acetonitrile is rapidly injected into a 
large excess of water with sonication. The formation of nanoparticles is driven by 
hydrophobic interaction of the polymer chains and accelerated by ultra-sonication. 
After removing the organic solvents by evaporation, water dispersible conjugated 
polymer nanoparticles with size in the range of 5-150 nm can be obtained.26 The 
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combination water solubility/dispersibility and the optoeletronic properties of 
conjugated polymers allows them to be studied as biological sensor for metal ions, 
DNA detection, and protein detection, as well as fluorescence imaging in vitro and 
in vivo.20 It represents a novel and very promising direction in cross-disciplinary 
areas of chemistry, material science, and biological science. 
Water soluble conjugated polymer based sensors are sensitive to minor 
perturbations, due to amplification by the light-harvesting response, which offers 
advantages when compared with small molecule counterparts. The 
light-harvesting response influence optoeletronic properties, such as absorbance, 
fluorescence resonance energy transfer (FRET), electrical conductivity and 
fluorescence efficiency, which can be used to transducer target analyte presence.22 
The amplified fluorescence quenching of conjugated polymers was demonstrated 
by Swager et al in 1995.11 The amplified quenching effect allows design 
conjugated polymer based protein and DNA sensors by monitoring the 
fluorescence change of conjugated polymers in the absence and presence of 
analytes.19 “Qencher-tether-ligand” QTL approach was one of the earliest protein 
assays that operate on conjugated polymer fluorescence quenching and 
de-quenching.27 (Scheme 1.3)The approach involved the use of a biotin linked 
cationic quencher (Methyl viologen MV). The fluorescence of anionic PPV in 
aqueous solution was superquenched by a small amount of biotin-linked MV 
(B-MV). Upon addition of avidin, the fluorescence of PPV was recovered due to 
the strong specific interaction between avidin and botin resulting in removal of 
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B-MV from the vicinity of PPV.  
 
Scheme 1.3 (a) Amplification of fluorescence quenching sensitivity. (b) QTL  




Scheme 1.4 Illustration of (a) the displacement of a quenched fluorescent PPT by 
protein analyte (in blue) from gold NPs to recover the fluorescence, and (b) 
unique fluorescence pattern generation through differential release of PPEs. 
Reproduced with permission from ref 29.  
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Heeger, Bazan, and co-workers discovered the fluorescence of cationic water 
soluble polyfluorene can be super-quenched by the addition of minute amount of 
gold NPs of different sizes.28 These gold NPs display apparent Stern-Volmer 
constants (Ksv) that in the range of Ksv = 107 - 1011. The authors assumed that the 
quenching occurs by a static mechanism, which is generally the case as the 
emissive lifetime of conjugated polymers are in the range of 0.3-0.7 ns. Making 
use of the super-quenching behavior Rottelo and coworks in 2007 (Scheme 1.4) 
created a sensor array containing six non-covalent gold nanoparticles-conjugated 
polymer complexes to detect, identify and quantify protein targets.29 The 
fluorescence of conjugated polymer is quenched by gold anoparticles; and the 
presence of proteins disrupts the nanoparticle-polymer interaction, producing 
distinct fluorescence response patterns. The patterns are highly repeatable and are 
characteristic for individual proteins at nanomolar concentrations, and can be 
quantitatively differentiated by linear discriminant analysis. The authors 
successfully used their method to identify 52 unknown protein samples with an 
accuracy of 94.2%. 
Apart from biosensing application, in recently years, fluorescent conjugated 
polymers emerged as a novel class of imaging agent because of their prominent 
properties, such as high fluorescence quantum yield, tunable emission, and good 
photostability, low cytotoxicity etc.30 As a fundamental exploration, most of 
investigations focus on in vitro applications. Nonspecific or specific targeting 
polymers were both developed for imaging application. In 2007, Moon prepared 
11 
 
stable PPE-based conjugated polymer nanoparticles via phase inversion 
precipitation for live cell imaging.31 The obtained nanoparticles exhibited an 
average size of 93 nm with a quantum yield of 0.17 in water. Both live an fixed 
BALB/C3T3 cells were successfully stained by the nanoparticles. The location 
was mainly in the cytosol (likely in endosomes or lysosomes), especially around 
the perinuclear region. Cell viability analysis indicated that the nanoparticles 
showed low cytotoxicity to baby hamster kidney cells over 1 week of culture. 
Photobleaching experiment in fixed BALB/C3T3 cells demonstrated that the 
nanoparticles possessed excellent photostability, which was ascribed to the 
assumption that the hydrophobic side-chains of the polymer consistuted a 
protective layer that prevented the destructive ROS from diffusing into the internal 
conjugated backbones. 
 
Figure 1.2 Bright-field and fluorescence imagings of live (a) and fixed (b) 
BALB/C 3T3 cells. CPNs and  Hoechst nucleus dye were highlighted in green 
and blue, respectively. Reproduced with permission from ref 31. Copyright 2007 




Recently, Wang and co-workers reported a label free OEG-pendent PPV for the 
detection and imaging of apoptotic cells via nonspectific interactions (Figure 1.3).32 
By inducing Jurkat T cells to sufferfrom apoptosis with anti-Fas mAbs, a series of 
apoptosis-related changes in the cells occurred. Taking advantage of the increased 
negative charge density and enhanced membrane permeability in apoptotic cells, 
the low cytotoxic cationic conjugated polymers was efficient enough to selectively 
bind and successively enter into the cells, resulting in the intense green emission. 
In contrast, normal cells without treatment with anti-Fas mAs were seldom stained 
by the polymer as a result of the effect of OEG side-chains to eliminate 
nonspecific interactions. In addition, the developed fluorescent probe was also 
compatible with flow cytometry to quantitatively examine the apoptotic 
percentage. 
 
Figure 1.3 Bright-field image and fluorescence image of Jurkat T cells induced 
with anti-Fas mAb followed by staining with polymer. Reproduced with 
permission from ref 32. Copyright 2011 Royal Society of Chemistry. 
 
In terms of specific targeted cell imaging, generally, conjugated polymers are 
modified with some specific recognition elements, such as antibody, peptide, 
sugar, protein, vitamin, etc, to attain the aim of selective binding.33 Conjugated 
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polymers functionalized with different specific targeting agents for cell imaging 
has been studied by several groups. Bunz and co-workers firstly realized this 
vision by using a newly designed anionic folate-functionalized PPE, by 
postfunctionalization of PPE side-chains with folic acid by EDC/NHS reaction.34 
In contrast to FR-negative NIH 3T3 cells, the obtained polymer was able to 
selectively recognize the image FR-overexpressed KB cells. The 
FR-mediatedendocytosisand the cytoplasmic localization were confirmed by 
fluorescence microscopy.  
a
b
Figure 1.4 (a) Schematic representation of fabrication and functionalization of 
CPNs for bioorthogonal labeling cell surface using click chemistry. (b) 
Fluorescence images of CPN-alkyne-labeled AHA-treated MCF-7 cells in the 
presence of reducing agents (sodium ascorbate). Reproduced with permission 
from ref 37. Copyright 2010 Wiley-VCH Verlag GmbH & Co. KGaA. 
14 
 
Conjugated polymer nanoparticles with red and green emission were 
functionalized with different targeting agents and were demonstrated to 
discriminate and image cancer cells from normal cells by Liu and co-workers.35 
By means of reprecipitation method, Christensen and co-workers prepared 
conjugated polymer nanoparticles for extracelluar targeting labeling.36 Chiu and 
co-workers developed conjugated polymer nanoparticles as a class of ultrabright 
probes for specific subcellular imaging. Compared to QD 565 and IgG-Alexa448, 
the CPNs exhibited excellent brightness and photostability.37 Specific fluorescent 
labeling of the cell surface was realized. 
  As the successful imaging application of fluorescent conjugated polymers in 
vitro, researcher further explored the possibility of them to be used for probing 
more important ex/in vivo biological processes. Chiu and co-workers further 
meliorated the recognitions system and achieved a in vivo tumor targeting 
imaging by use of their ultrabright CPNs.38 The CPNs were composed of 
functional PSMA and deep-red emissiveconjugated polymer blends (PSMA as the 
donorand PF-DBT5 as the acceptor). after covalent modification with a 
medulloblastoma-specific peptide chlorotoxin (CTX) and PEG, the photostable 
and serum-stable CTX-CPNs were subjected to malignant brain tumor imaging in 
a transgenic mouse model (ND2:SmoAl) via tail vein administration. The 
fluorescence images of mouse brains taken after 72 h of injection showed that the 
preponderant accumulation was observed only for the group of 
ND2:SmA1/CTX-CPNs, indicating the specific binding. 
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The bright fluorescent of conjugated polymers also was demonstrated for the 
possibility of in vivo imaging and drug tracking. Liu and co-workers prepared 
cisplatin-loaded NPs (CPE-PEG-Pt, with an average size of 122 nm) by linking 
PEG-grafted red-fluorescent CPNs with cisplatin via a ligand exchange reaction.39 
The CPE-PEG-Pt displayed a slow but persistent behavior of cisplatin releasing in 
PBS buffer. The CPE-PEG-Pt was injected into BALB/C nude mice through tail 
veins. Non-invasive live animal fluorescence imaging indicated the capability of 
the established NIR fluorescent probe to imaging in vivo. During the whole 
experimental process, the region of the liver was the main distribution site of 
Pt-CPNs. The CPE-PEG-Pt could be cleared away from the body to a certain 
extent, monitored by time-dependent signal decreasing. Moreover, the fluorescent 
signal can be simultaneously used for monitoring the drug distribution. 
 
1.2 Two-photon absorption materials 
1.2.1 Two-photon absorption 
Two-photon absorption (TPA) is the simultaneous absorption of two photons in 
order to excite a molecule from the ground state to excited state (Scheme 1.5).  
This theoretical concept of TPA process was first proposed by Maria 
Goppert-Mayer in 1931 in her doctoral dissertation.40 She introduced the concept 
of an intermediate state and derived and expression of the TPA probability which 
involve the summation over all eigen-states of a molecular system.41 TPA only 
occurs under light with very high intensity, which as a mere fantasy until the 
16 
 
invention of laser in the 1960s. In 1961, two-photon absorption was 
experimentally verified by Kaiser and Garret with the two-photon excitation of 
























Scheme 1.5 Jablonski energy diagram for one-photon and two-photon absorption. 
 
TPA has different selection rules with one photon absorption in that the TPA 
probability of molecules in a given position is proportional to the square of the 
local light intensity as shown in the expression: 
 
Where I is the local light intensity with the sample, z is the position along the 
beam propagation direction within the sample, β is the TPA coefficient. The TPA 
coefficient β is a macroscopic parameter that depends on the concentration of the 
two-photon absorbing molecules. Often, the individual molecule’s or 
nanoparticles’ TPA properties is described by the TPA cross-section δ2. The 




Where N is the number density of the molecules or nanoparticles in the system 
and ħω is the energy of photon of the excitation light. The common used unit of 
TPA cross-section is GM (the name abbreviation of Goppert-Mayer), defined by 
1 GM = 10-50 cm4 s 
  The TPA cross section δ can be strongly influenced by the measurement 
technique because of a variety of artifacts. Two main techniques for measuring 
TPA cross sections are known as z-scan and two-photon excited fluorescence 
(TPEF).44 For fluorescent samples, the TPEF method is a more popular and 
convenient method providing direct information of the efficiency of TPA. Several 
variants of this experiment have been well developed since it was first reported by 
Xu and Webb.45 The TPA cross section of sample can be measured by comparing 
to a stander fluorescent sample, of which the TPA cross section value and the 
quantum yield of TPA induced fluorescence at a given excitation wavelength are 
known. 
  Because TPA is quadratically dependent on light intensity, the probabilities of 
TPA sharply decrease with the distance from the focal. For a tightly focused laser 
beam, the intensity is maximal at the focus and deceases quadratically with the 
distance (z) from the focal plane in the beam direction. Therefore, the probability 
of which two-photon materials are excited decreases very rapidly with the 
distance (as z-4) from the focal plane. This feature, together with the exponential 
distribution of the intensity with the focal point, confines TPA only in a small 
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volume around the focus point. It allows researcher to achieve three-dimensional 
(3D) spatial resolution for two-photon induced chemical or physical processes in 
materials. In addition, the excitation wavelength used for two-photon excitation is 
generally twice than that for one-photon excitation, resulting in less scattering and 
deeper penetration depth.46  
The features of TPA technique have great potentials of various applications, 
including 3D optical microfabrication,47 frequency-upconversion imaging and 
microscopy,48 optical data storage and processing,49,50 and two-photon associated 
biological and medical applications.51,52 The interesting potential applications of 
TPA materials promoted the rapidly expanding studies of two-photon active 
materials.44 
 
1.2.2 Two-photon absorption materials and conjugated polymers 
π-conjugated organic molecules are an important class of two-photon absorption 
materials.44,53,54 The structures-properties relationships of organic molecules have 
been well investigated experimentally and theoretically for improvement of the 
two-photon absorbability, which is characterized by the TPA cross section. 
Presence of electron donor component (D), electron acceptor component (A) and 
π-bridge is the key molecular feature for design a molecule with large TPA cross 
section.  In addition, coplanarity and the extent of conjugation have been 
identified as critical to the TPA cross section.  Molecules with large TPA cross 
section have been investigated, including linear donor-π bridge-donor (D-π-D), 
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acceptor-π bridge-acceptor (A-π-A) and donor-π-acceptor-π-acceptor-π-donor 
structures, as well as quadrupolar, octupolar structures and π-bridge linked 
bi-porphyrins. 
Nanoparticles such as novel metal and semiconducting nanoparticles have also 
been investigated for their two-photon absorption properties. The TPA action cross 
sections of gold nanorods were determined to be ~2000 GM, and they have been 
demonstrated as contrast agent for in vitro and in vivo two-photon luminescence 
imaging.55,56 Colloidal CdSe quantum dots also exhibit large TPA cross section 
(from 2000 to 47000 GM).57 They appear to be promising probes for two-photon 
microscopy.58 
 
1.2.3 Conjugated polymers as two-photon light harvesting materials 
Conjugated polymers as two-photon absorption materials are particular interest 
due to their extended delocalization π-electrons along the polymer backbone 
which could enhance TPA cross sections.44 The largest TPA cross section (>10000 
GM) has been reported for a ladder-type polymer with low flexibility, high 
planarity, and good effective conjugation.59 Conjugated polymers with large 
two-photon absorption cross sections are attractive for various applications.60,61 
Conjugated polymers can be acted as two-photon light harvesting materials for 
amplification of the two-photon properties of small molecular dyes/drugs. 
Our group first reported enhanced two-photon excitation fluorescence by FRET 
from a cationic conjugated polymer 
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poly(9,9-bis(6-N,N,N-triethylammoniium)-hexyl-fluorene phenylene) (PFP) to a 
DNA intercalator, an oxazole yellow dimer (YOYO-1) (Scheme 1.6).62 PFP was 
used as two-photon excitation light-harvesting complex and energy donor, and 
YOYO-1 was chosen as an energy acceptor because its absorption spectrum 
overlaps well with the emission spectrum of PFP. YOYO-1 has a relatively high 
affinity to DNA. Its fluorescence intensity increases over 460 times upon 
intercalation into dsDNA. Upon adding cationic conjugated polymer PFP, the 
electrostatic interactions between PFP and dsDNA can bring the donor and 
acceptor into proximity, enabling efficient energy transfer to occur. 
 
Scheme 1.6 Illustration of the two-photon excitation fluorescence resonance 
energy transfer (TPE-FRET) system. 
 
Porphyrin-based systems are widely used as photosensitizers for photodynamic 
therapy and drug releases. In the follow up work, our group demonstrated a novel 
electrostatic assembly, a cationic conjugated polyelectrolyte PFP and a negative 
charged hematophophyrin (HP), with efficient one- and two-photon excitation 
FRET from PFP to the HP photosenstizizer.63 The electrostatic interaction between 
PFP and HP brings them into close proximity, ensuring FRET occurs. It was found 
an amplification of over 9-fold and 30-fold in the HP emission intensity in the 
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presence of PFP for one-photon excitation FRET and two-photon excitation FRET 
(at 800 nm), respectively. The amplification factor by two-photon excitation FRET 
is very close to the estimated value, confirming that the enhancement is indeed a 
result of two-photon excitation energy transfer. 
Schanze and coworkers reported two-photon excited fluorescence from a 
water-soluble anionic poly(phenyleneethynylene) (PPESO3), amplified quenching, 
and its application to two-photon fluorescence microscopy imaging in Hela 
cells.64 They found that the quenching effect of PPESO3 by DODC under 
two-photon excitation is slightly larger than that under one-photon exciation. The 
Stern-Volmer constant under two-photon excitation is about 2.5 × 106 M-1, 
slightly larger than that observed under one-photon excitation (~1.5 × 106 M-1). 
Besides, they demonstrate the PPESO3 and PPESO3-coated silica nanoparticles 
both are suitable for cellular imaging by two-photon excited fluorescence 
microscopy. 
With the development of two-photon excited fluorescence laser-scanning 
microscopy (2PLSM), combined with in vivo fluorescence labeling techniques, 
two-photon excited fluorescence imaging has been used as a useful tool to study 
the in vivo microscopic physiological studies. Water soluble CPs with high 
quantum yield, good photostability, large TPA cross sections and low toxicity are 
promising materials for two-photon biological imaging applications. Moon et al 
demonstrated water soluble CPs for two-photon imaging of endothelial cells in a 
tissue model (Figure 1.5).60 The water soluble CPs acetic acid-treated 
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poly(p-phenylene ethynylene) PPE forms aggregates at about 8 nm, and size of 
the water soluble CPs nanoparticles increases to ~ 50 nm upon more than six 
months storage, which is ascribed to the aggregation of the polymers chains 
induced by the slow leaching-out of the residual acetic acid from the aggregates 
over the 6 months. The water soluble PPE nanoparticles showed cross sections 
range between 1000 and 11000 GM with a maximum per particles at about 730 
nm, higher than that of some quantum dots such as QD525. Their results showed 
the photostability during the hour of continuous irradiation indicated high 
resistance to bleaching in PPE that is compatible to QDs. They found that the PPE 
is nontoxic and persist in the cells, indicating its suitability as a long-term 
intracellular marker. The hydrophilicity and nontoxicity of PPE nanoparticles 
allow for long-term monitoring of angiogenesis by endothelial cells in a tissue 





Figure 1.5 Fluorescence images of cultured HMVE-d cells in a microfluidic 
device. two-photon excitation images showing projection of capillary structures 
through 90 mm of central gel region. Reproduced with permission from ref 37. 
Copyright 2010 Wiley-VCH Verlag GmbH & Co. KGaA. 
 
1.3 Photodynamic therapy 
1.3.1 Photodynamic therapy 
  Photodynamic therapy is a medical treatment which employs the combination 
light and photosensitizers to bring about a cytotoxic effect to cancerous or 
diseased tissue.65-67 Upon absorption of a photon, the photosensitizer is promoted 
to its singlet excited state followed by intersystem crossing to excited triplet 
state.68 The triplet can participate in a one-electron oxidation-reduction reaction 
(Type I photochemistry) with a neighboring molecule, producing free radical 
intermediates that can react with oxygen to produce peroxy radicals and various 
reactive oxygen species (ROS). Alternatively, the triplet state photosensitizer can 
transfer its energy to ground state oxygen (Type II photochemistry), generating 
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singlet molecular oxygen, a highly oxidative species that reacts with many 
biological molecules, including lipids, proteins, and nucleic acids (Scheme 1.7).66 
The high reactivity of singlet oxygen comes from the high oxidative activity by 
the unoccupied π* orbital, which is produced by pairing of two electrons into one 
of the 2pπ* orbital. (Scheme 1.8) 
 
Scheme 1.7 Diagram of type II photochemistry in PDT. 
 
Scheme 1.8 Electronic structures of ground state oxygen (3O2) and singlet oxygen 
(1O2). 
 
Singlet oxygen plays an important role in PDT. Efficient photosensitizers in 
PDT should have good singlet oxygen generation ability.68 The singlet oxygen 
generation yield of a photosensitizer can be measured by direct detecting 
photoluminescence of singlet oxygen at about 1270 nm.69 Alternatively, singlet 
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oxygen generation ability can be examined by monitoring the oxidation of a 
chemical probe which can be oxidized by singlet oxygen, causing it absorbance 
decrease.70 
The most common photosensitizers used in PDT studies are porphyrin 
compounds including chlorines and phthalocyanines.67 Typically, phophyrins have 
a absorption maximum (Soret band) in UV range (~400 nm), and several very 
weak absorption bands in visible range. Among them, Photofrin is the only 
commercially available photosensitizers, which has a useful absorption peak at 
630 nm with low molar absorption coefficient (1170 M-1cm-1).71 The disadvantage 
of current available PDT is the low penetration depth of the visible light because 
of the absorption and scattering of biological tissues. Table 1.1 show the 
wavelength-dependent penetration depth of light as the distance where the 
incident light intensity is reduced to 1/e. Generally, the penetration depth ranges 
between 0.5 and 1.5 mm at the wavelength from 480 to 600 nm and gradually 
improves to 4-5 mm with the increase of wavelength.72 




1.3.2 Two-photon photodynamic therapy 
The application of conventional PDT is hindered by a limited light penetration 
depth into tissues in the visible range and a lack of selectivity in the z-direction. 
Two-photon PDT is one of promising approaches to increase light penetration into 
body tissues as it uses excitation sources of longer wavelengths that fall within the 
tissue transparency window (750 to 1100 nm).73,74  In addition to deeper 
penetration depth, another major advantage of TPA is that the quadratic 
dependence of two-photon absorption on laser intensity allows high spatial 
selectivity by focusing the laser beam at a focal point. The integration of TPA with 
PDT provides a promising tool for improving treatment of deeper tumors with 
enhanced spatial resolution and minimal damage to adjacent healthy tissue. 
In 1990s, two-photon PDT has been proposed and studied by some research 
groups.75 The studies could not attract a lot of attention because TPA efficiencies 
of photosensitizers used in those studies were low with TPA cross section value 
bellow 50 GM. For example, the TPA cross section value of proptoporphyrin IX is 
known to be only ~2 GM.76 To sufficiently make use of the advantages of 
two-photon PDT, it turns to be critical to develop photosensitizers with large TPA 
cross sections and efficient two-photon induced singlet oxygen generation 
abilities.  
Many efforts have been made to improve the TPA efficiencies of 
photosensitizers through syntheses of new photosensitizers or chemical 
modification of porphyrins with large TPA cross sections.77-81 Alternatively, 
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resonance energy transfer schemes from materials with large TPA cross sections to 
photosensitizers have been made to enhance the TPA efficiencies of 
photosensitizers. Although dendrimers, Silica or polymeric nanoparticles 
encapsulating both TPA dyes and photosensitizers have been designed and studied 
by some research groups to make use of TPA dyes to amplify the singlet oxygen 
generation ability,82-84 there are few study on in vivo two-photon PDT which could 
be mainly due to the lack of efficient amplification capability of these systems to 
enhance the PDT effect. Thus, the development of novel two-photon 




1.4 Objective and scope of thesis 
As discussed in above sections, conjugated polymers have received lots of 
attentions for biological applications due to their unique optical properties and 
good biocompatibility. The two-photon light harvesting properties of conjugated 
polymers also indicates their great promise in potential two-photon biological 
application. However, to date, there are few reports on two-photon biomedical 
application of conjugated polymers. 
  The purpose of this thesis is to develop conjugated polymers for two-photon 
biomedical applications, especially for two-photon PDT and two-photon imaging 
applications. To this end, conjugated polymers will be synthesized and conjugated 
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polymer nanoparticles will be prepared. Their one-photon and two-photon 
photo-physical and photochemical properties will be studied. Furthermore, we 
will study the two-photon induced singlet oxygen generation ability of the 
conjugated polymers or conjugated polymer nanoparticles and their two-photon 
PDT effect on cancer cells. At last, conjugated polymer nanopartiles with efficient 
two-photon induced singlet oxygen generation efficiency will be developed and 
demonstrated for targeted two-photon PDT application on cancer cells. 
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Water-soluble conjugated polymers for amplification of one- 
and two-photon properties of photosensitizers 
 
2.1  Introduction  
Chromophores can simultaneously absorb two photons to be promoted onto the 
excited state in the presence of intense laser irradiation, which is known as two-
photon absorption (TPA). The transition probability from the ground state to the 
excited state is proportional to the square of the incident beam intensity, which 
allows three-dimensional (3D) spatial resolution for two-photon induced chemical 
or physical processes in materials. Two-photon absorption materials have many 
potential and promising applications such as two-photon photodynamic therapy 
(PDT),1,2 fluorescence microscopy,3,4 3-D microfabrication and optical data 
storage.5 These potential applications have strongly stimulated the research 
activity on materials with large two-photon absorption cross sections (δ) in 
aqueous media.1-6 
Photodynamic therapy (PDT) has been known as a non-invasive treatment 
method and has been used for treatment of several types of cancer.7-9 Two-photon 
photodynamic therapy (TP-PDT) and imaging have advantages over their one-
photon counterparts by offering the advantages of a) the ability to treat deeper into 
diseased tissues; b) the ability to work with a smaller, more confined treatment 
area; and most importantly, c) TP-PDT renders selective photodynamic activity in 
z-direction, which significantly reduces side effects. Furthermore, the 
photosensitizers for TP-PDT are not limited to those absorbing at longer 
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wavelengths, thus the choice of photosensitizers is more versatile and flexible. 
However, conventional photosensitizing drugs in clinical use usually have small 
two-photon absorption cross sections and their efficiencies are limited.10-12 To 
make TP-PDT more generally applicable, design of new photosensitizers or 
chemical modification of existing ones to produce efficient two-photon 
sensitization is required, which is however complex, expensive and needs long 
periods.13-16 An alternative method is to use materials with large TPA cross 
sections as two-photon light harvesting complexes in combination with existing 
photosensitizing drugs. In this approach, materials with large TPA cross sections 
act as energy donor to transfer the harvested energy to the photonsensitizers 
(acting as acceptor). The photosensitizer molecules are thus indirectly excited 
through two-photon excitation fluorescence resonance energy transfer (TPE-
FRET). The efficiency of the existing drug molecules could be significantly 
enhanced through fluorescence resonance energy transfer. Based on this concept, 
different TPE-FRET schemes have been developed,17-22 in which the TPA donors 
and photosensitizer are assembled together to achieve enhanced two-photon 
photosensitizing activity. These approaches include chemically assembling TPA 
donors into dendrimer arms with a photosensitizer moiety as the central core,20 
assembly or covalently linking photosensitizer molecules with materials with 
larger TPA cross sections such as semiconducting nanoparticles,18 small 
molecules17, 19 and conjugated polymers.21, 22 In these assemblies, materials with 
large TPA cross sections act as two-photon light harvesting complexes to enhance 
two-photon excitation efficiency of the photosensitizers. 
Water-soluble conjugated polymers have been known to display excellent light-
harvesting property and can result in fluorescence amplification of organic dyes in 
 35 
aqueous media through FRET.23-26 This property has been widely used for 
developing novel biosensors with enhanced sensitivity.23-26 In addition, conjugated 
polymers also have large TPA cross sections compared to their small molecule 
counterparts.1, 27, 28 Water-soluble conjugated polymers have been utilized to 
enhance two-photon property of photosensitizers and organic dyes in aqueous 
media through FRET.21, 22 The two-photon excitation fluorescence of the 
photosensitizer molecules and dyes has been reported to be enhanced by a factor 
of over 30 times based on commercially available conjugated polymers.21, 22 There 
are still a lot of room for further improvement in enhancement factor if conjugated 
polymers with optimized structures and large TPA cross sections are used, which 
will be particularly useful for clinical applications.  
Many different strategies have been used to improve TPA cross section of 
molecules, particularly at 800 nm, the central wavelength of most readily 
available femtosecond laser source used in many applications. Several factors, 
including the properties of π-conjugated segment, electron donating/withdrawing 
strength of donor and/or acceptor substitutes, molecular symmetry, and the 
molecular dimensionality have been known to play important roles in the TPA 
cross section of organic molecules.1 A few recent studies showed that TPA cross 
sections of organic molecules can be improved by orders of magnitude through 
increasing the conjugation length and coplanarity.29-32 It has also been reported 
that the solvent also played an important role in the TPA cross section of 
conjugated polymers.28, 33, 34 The TPA cross sections of conjugated polymers in 
aqueous media were reported to be much smaller than those in organic solvents, 
which will restrict their enhancement capability in biological applications. There 
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is strong demand to develop new water-soluble conjugated polymers with 
improved TPA cross sections. 
In this work, we have designed and synthesized two new cationic conjugated 
polymers (CCPs) with improved TPA cross sections at 800 nm, which were 
subsequently utilized as two-photon light harvesting complex to enhance two-
photon excitation emission of photosensitizers. These two polymers, poly[9,9’-
bis(6’’- (N,N,N-trimethylammonium)-hexyl)fluorene-2,7-ylene-ethylene-co-alt-
1,4-phenylene] (PFE) and poly[9,9’-bis(6’’-(N,N,N-trimethyl-ammonium)-
hexyl)fluorene-2,7-ylene-vinylene-co-alt-1,4-phenylene] (PFV), have modified 
backbone structures from poly [9,9’-bis(6’’-(N,N,N-trimethylammonium)-
hexyl)fluorene-co-alt-1,4-phenylene dibromide] (PFP), a cationic conjugated 
polymer that was previous utilized as two-photon light harvesting complex.21, 22 
By inserting vinylene and ethynylene units as the bridges, which changed 
conjugation delocalization and rigidity of the polymer backbones, the TPA cross 
section of the two new CCPs at 800 nm have been significantly improved 
compared to PFP.  The TPA cross sections of PFV (with the vinylene bridge) and 
PFE (with the ethynylene bridge) at 800 nm are 36 times and 8 times of that of 
PFP. The improved TPA cross sections of CCPs at 800 nm make them useful in 
acting as two-photon light harvesting complexes to significantly enhance two-
photon excitation emission of photosensitizer, Rose Bendgal (RB), via FRET. The 
two-photon emission of RB under excitation at 800 nm was found to be enhanced 
by up to about 20 times when PFE was used and more than 85 times when PFV 
was used, respectively. Our results will provide useful information for the further 
application of CCPs in the field of two-photon PDT, sensing and imaging. 
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2.2  Experimental section  
Materials and measurements: Solvents and chemicals were purchased from 
Sigma-Aldrich and used without further purification unless otherwise noted. THF 
was dried and distilled under sodium. Polymers PFP and PFV were synthesized 
using a procedure as described in the literature and shown in Scheme 1.35, 36 2,7-
Diiodo-9,9-di(6’-bromohexy) fluorene (1),37 2,7-Dibormo- 9,9-di(6’-bromohexy) 
fluorene (4),35 1,4-bis(diethylphosphinatyl methyl) phenylene (6)38 were prepared 
according to the reported procedures.  
1H-NMR and 13C-NMR spectra were recorded on 300 MHz AC Bruker 
spectrometers. Mass spectra were measured by using an AEI-M850-MS 
spectrometer. FT-IR spectra were taken on a Varian 3100 FT-IR spectrometer in a 
KBr pellet form. GPC analysis was carried out on a Waters Styragel system using 
polystyrene as the calibration standard and tetrahydrofuran (THF) as eluent. UV-
vis absorption and fluorescence spectra were measured by using a Shimadzu UV-
2450 spectrophotometer and a Perkin Elmer LS50 spectrophotometer, 
respectively. The emission quantum yields (QE) of the polymers were measured 
by using quinine sulfate (0.1 M H2SO4) and Rhodamine 6G in methanol as 
standards.  
The two-photon excitation fluorescence measurement was performed by using 
Spectra Physics femtosecond Ti:sapphire oscillator (Tsunami) as the excitation 
source. The output laser pulses have a center wavelength at 800 nm with pulse 
duration of 40 fs and a repetition rate of 76 MHz. The laser beam was focused 
onto the samples contained in a cuvette with path length of 1 cm. The emission 
from the sample was collected at a 90° angle by a pair of lenses and an optical 
fiber that was connected to a monochromator (Acton, Spectra Pro 2300i) coupled 
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with CCD (Princeton Instruments, Pixis 100B) system. A short pass filter with 
cut-off wavelength at 700 nm was paced before the spectrometer to minimize the 
scattering from the pump beam. All the measurements were performed in 
phosphate buffer (25 mM, pH=7.5) solutions at room temperature. 
Preparation of 2,7-Bis[(trimethylsilyl)ethynyl]-9,9-di(6’-bromohexy) fluorene 
(2): A solution of 2,7-Diiodo-9,9-di(6’-bromohexy)fluorene (1.48 g, 2 mmol), 
copper iodine (80 mg, 0.42 mmol) and triethylamine (2 mL, 14 mmol) in 20 mL 
of THF were stirred under N2 for 30 min. Trimethylsilyl acetylene (490 mg, 
5mmol) and Pd(PPh3)2Cl2 (50 mg, 0.072 mmol) were then added and the mixture 
were stirred for 24h at room temperature. After removing the solvent in vacuo and 
purification procedures by passing through a silica gel column using 
DCM/Hexane=1:10 as the eluent, a yellow solid product (800 mg, 59%) was 
obtained. The NMR and mass spectra results are a) 1H NMR (300MHz, CDCl3): δ 
7.59 (d, 2H), 7.46 (d, 2H), 7.41(s, 2H), 3.28(t, 4H), 1.97-1.91(m, 4H), 1.70-
1.60(m, 4H), 1.16-1.08(m, 8H), 0.53(m, 4H), 0.29(s, 18H); b)  13C NMR 
(300MHz, CDCl3): 150.5, 140.8, 131.4, 126.1, 121.9, 119.9, 105.9, 94.5, 55.1, 
40.2, 33.9, 32.7, 29.0, 27.8, 23.4, 0.04; c) MS (EI): m/z= 685 (M+). 
Preparation of 2,7-Diethylnyl-9,9-di(6’- bromohexy)fluorene (3): Monomer 2 
(680 mg, 1 mmol) and potassium carbonate (1.38 g, 10 mmol) were mixed into 50 
mL of methanol and the solution was stirred overnight at room temperature. Then 
the solvent was stripped off under reduced pressure. The residue was dissolved 
into 100 mL of chloroform. The organic solution was washed successively with 
1.0 M aqueous HCl and water, and then dried over anhydrous MgSO4. A yellow 
oil product (460 mg, 95%) was obtained after the solvent was removed. The NMR 
and mass spectra results are a) 1H NMR (300MHz, CDCl3): δ 7.62 (d, 2H), 7.49 
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(d, 2H), 7.45(s, 2H), 3.28(t, 4H), 3.16(s, 2H), 1.98-1.92(m, 4H), 1.68-1.61(m, 4H), 
1.16-1.08(m, 8H), 0.62-0.54(m, 4H); b) 13C NMR (300MHz, CDCl3): 150.8, 
141.0, 131.4, 126.5, 120.9, 120.0, 72.7, 58.4, 55.1, 40.2, 33.9, 32.7, 29.0, 27.8, 
23.6; c) MS (EI): m/z= 540 (M+). 
Preparation of  poly[9,9’-bis(6’’-(bromohexyl) fluorene-2,7-yleneethylene-co-
alt-1,4- phenylene] (PFE-Br): 1,4-dibromophenylen (128 mg, 0.5 mmol), 
Monomer 3 (270 mg, 0.5 mmol), Pd(PPh3)2Cl2 (50 mg, 0.072 mmol) and 
cuprous iodide(19.2 mg, 0.1 mmol) were combined in degassed toluene (10mL) 
and diisopropylaine (4 mL). The reaction mixture was stirred at 70℃ for 24h. 
After cooling to room temperature, the solvent was removed under vacuum. The 
residue was dissolved into 50 mL of chloroform and washed with water. The 
organic layer was dried over with MgSO4, and then precipitated in methanol. The 
precipitate was filtered off and re-precipitated twice in methanol to afford the 
brown solid product (180 mg, 58%). NMR spectra FTIR and GPC results are a) 
1H NMR (300MHz, CDCl3): δ 7.72(br, 2H), 7.58-7.49(br, 8H), 3.26(br, 4H), 
2.08(br, 4H), 1.63-1.55(br, 4H), 1.15-1.07(br, 8H), 0.65(br, 4H); b) FT-IR (KBr, 
cm-1): 2931~2858 (υC-H, υAr-H) ), 2201(υC≡C), 1653~1606(υAr,C=C), 
1465~1436 (δC-H), 1267~1233 (υC-C of Fluorene), 1161~1123( weak，υR,C-C) 
, 1070~1008(υC-C of Fluorene), 894(υ≡C-C), 825(δC-H of p-Ar), 750(δAr,C-H), 
726(δ (CH2)n, n≥4), 690~646(υC-H of Fluorene), 560~526(νC-Br); c) GPC: 
Mn=13181, Mw=31926, PDI=2.42. 
Preparation of the ionic polymers: PFP-Br, PFE-Br and PFV-Br were dissolved 
into 20 mL of chloroform. 5 mL of trimethylamine solution in ethanol (30%) were 
then added. The mixture was stirred for 48 h at room temperature. The solvent 
were then evaporated at vacuum and ionic polymers were obtained after dried at 
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vacuum.  1H NMR (300MHz, d-DMSO) for a) PFP: δ 8.09-7.58(m, 10H), 3.17(br, 
18H), 2.98(br, 4H), 2.14(br, 4H), 1.47 (br, 4H), 1.08 (br, 8H), 0.54(br, 4H); b) 
PFE: δ 8.01-7.55(m, 10H), 3.17(br, 18H), 2.99(br, 4H), 2.07(br, 4H), 1.47 (br, 
4H), 1.07 (br, 8H), 0.54(br, 4H); c) PFV: 1H NMR (300MHz, DMSO-d6)  δ 8.09-
7.27(m, 14H), 3.18(br, 18H), 2.95(br, 4H), 2.09(br, 4H), 1.45 (br, 4H), 1.26-
1.05(br, 8H), 0.54(br, 4H). 
 
2.3  Results and discussion 
2.3.1  Synthesis and physical properties 
Scheme 2.1 shows the synthesis routes of the conjugated polymers used in this 
study. Poly[9,9’-bis(6’’-(N,N,N-trimethyl-ammonium)-hexyl) fluorene-co-alt-1,4-
phenylene dibromide] (PFP) was synthesized using a previously reported 
method35 via the Suzuki reaction. Monomer 3 was prepared from 2,7-diiodo-9,9-
di(6’-bromohexy) fluorene and trimethylsilyl acetylene by a palladium(II)-
catalyzed cross-coupling reaction, followed by cleavage of the trimethylsilyl 
protecting group under basic condition. The neutral polymer, poly[9,9’-bis(6’’-
(bromohexyl) fluorene-2,7-yleneethylene-co-alt-1,4-phenylene] (PFE-Br), was 
prepared by palladium-catalyzed crossing-coupling condensation between 
monomer 3 and 1,4-dibromophenyl in the mixture of toluene/diisopropylaine 
(2.5:1) solution containing CuI under N2 at 70℃ for 24h. Monomer 5 was 
prepared from 2,7- dibromo-9,9-di(6’-bromohexy) fluorene with a yield of 55%. 
The bromides at the 2,7- position are activated by adding two equivalent of t-BuLi 
in dry THF at -78 ℃ and excess of N,N-dimethylformamide (DMF) and stirring 
the reaction mixture for overnight at room temperature. The poly[9,9’-bis(6’’-
(bromohexyl) fluorene-2,7-ylenevinylene-co-alt-1,4-phenylene] (PFV-Br) was 
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prepared via the Wittig-Horner condensation reaction between the dialdehyde 
monomer 5 and the 1,4-bis (diethylphosphinatyl methyl) phenylene in dry THF by 
slowly adding one equivalent of t-BuOK. The prepared neutral polymers PFE-Br 
and PFV-Br were then dissolved into chloroform and treated with 30% 
trimethylamine ethanol solution at room temperature for 48h to obtain water-













































































Scheme 2.1  Synthesis routes of monomers and conjugated polymers. 
 
The structures and purity of polymers were confirmed by using NMR 
spectroscopy and FT-IR spectra. As shown in Figure 2.1, the FT-IR spectrum of 
PFE-Br gives a weak characteristic absorption peak of -C≡C- at 2201 cm-1, which 
demonstrate the symmetrical structure and high molecule weight of the polymer 
PFE-Br. The absorption peak at 961 cm-1 of PFV-Br is due to the C=C bridge, 
which confirms the trans- configuration of the vinylene double bonds of PFV-Br. 
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The disappearance of the peak around 1650 cm-1 is due to a relatively high 
molecular weight of PFV-Br. The detail assignments of all peaks are summarized 
in the experimental section. 
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 Figure 2.1  FT-IR spectra of polymers PFE-Br, PFV-Br and PFP-Br. 
  
The weight averaged molecular weight (Mw) and number averaged molecular 
weight (Mn) with the polydispersity index PDI (PDI = Mw/Mn) of neutral 
polymers PFP-Br, PFE-Br and PFV-Br were determined by the gel permeation 
chromatography (GPC) analysis using THF as the eluent. The data are 
summarized in Table 1. Based on the molecular weight, the numbers of repeat 





Table 2.1  Polydispersity properties of polymers. 
Polymers Mw (g/mol) Mn (g/mol) PDI 
PFP-Br 17250 6880 2.51 
PFE-Br 31930 13180 2.42 
PFV-Br 31095 17140 1.81 
 
2.3.2 Absorption and fluorescence properties 
The absorption and fluorescence spectra of the polymers PFP, PFE and PFV in the 
aqueous media are shown in Figure 2.2 (a) and some optical properties are 
summarized in Table 2. The absorption spectrum of PFP exhibits a maximum at 
375 nm and the fluorescence spectrum peaks at 418 nm with a shoulder around 
430 nm, similar to other polyfluorene derivatives. Both absorption and 
fluorescence spectra of PFE and PFV are red shifted relative to those of PFP, 
which can be understood as a result of increasing conjugation length and extended 
delocalization along the polymer backbone chain upon inserting the vinylene and 
ethynylene units. The absorption spectrum of PFV is further red-shifted by 55 nm 
relative to that of PFE. These results suggest that the double bond allows better 
electron delocalization than the triple bond, similar to the previous studies on 
polyethylene and polyvinylene compounds.39 However, PFE and PFV exhibited 
similar emission spectra with the same emission maximum for the similar 
conjugation degree of fluorene units. The extinction coefficients (ε) of the 
polymers also increase upon inserting the vinylene and ethynylene bridges (Table 
2.2), which further confirms that PFV and PFE have larger effective conjugation 
lengths than PFP.40 The fluorescence quantum yields (η) of three polymers in 
water were measured by using quinine sulfate or rhodamine 6G as the standard. 
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The η value of PFP and PFE are similar (9.8%), while PFV has a relative lower η 
value (3.0%), probably due to a stronger self-quenching effect induced by the π-π 
stacking aggregation. 
Table 2.2  Photophysical properties of PFP, PFE, PFV and RB. 
Polymers λ abs. (nm) em.   (nm) ε  (M-1·cm-1) η (%) δ (GM) (800 nm) 
PFP 375 418 3.65 ×104 9.8 8.4 
PFE 382 483 3.73 ×104 9.8 67.3 
PFV 437, 464 484 4.17×104 3.04 305 
RB 550 568 1.95×104 0.84 21.0 
 
The TPA cross sections of three water-soluble conjugated polymers in water 
have also been measured by using rhodamine 6G in methanol and fluorescein (pH 
=11) as the standard. Although the TPA cross sections are strongly dependent on 
the excitation wavelength (Figure 2.2(b)), here we mainly focus our studies on the 
TPA cross sections of polymers at 800 nm due to its practical importance. The 
applications of two-photon excitation fluorescence microscopy and two-photon 
PDT usually use a Ti:sapphire oscillator, which has a central wavelength at 800 
nm. As summarized in Table 2.2, the TPA cross section of PFV at 800 nm is 305 
GM per repeat unit, which is 4.5 times that of PFE and 36 times that of PFP. If we 
consider the entire polymer chain, the TPA cross sections for PFP, PFE and PFV 
will be 100GM, 1410GM, and 8540 GM per polymer chain, respectively. 
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Figure 2.2  (a) UV-visible absorption spectra (solid line) and emission spectra 
(dash line) of PFP, PFE and PFV; (b) TPA cross section of polymer with different 
excitation wavelength. 
 
Two factors are responsible for much larger TPA cross sections (per repeat 
unit) of PFE and PFV at 800 nm compared to PFP. First, due to improved 
conjugation length and electron delocalization by inserting vinylene and 
ethynylene units, both one-photon and two-photon absorption peaks shifts to red. 
PFP has a one-photon absorption peak at 375 nm. Its TPA peak was known to be 
~650 nm,41 far away from 800 nm.  The red-shift in absorption spectra will help 
to increase TPA cross sections at 800 nm. Secondly, the improvement in 
conjugation length and electron delocalization will drastically increase the TPA 
responses of the conjugated polymers. It has been previously established that there 
is a strong correlation between electron delocalization and two-photon 
absorptivity.1 The extent of conjugation and coplanarity of the polymer chain have 
been known particularly important for improving TPA cross section of the 
materials. Larger conjugation and better coplanarity can lead to states with a larger 
extent of charge separation thus a larger TPA cross section. The TPA cross section 
of three polymers at different excitation wavelengths available from our laser 
system are summarized in Figure 2.2 (b).  
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2.3.3  One-photon excitation fluorescence resonance energy transfer.  
Rose Bengal (RB, its structure is shown in Figure 2.3(a)) is an important 
photosensitizer that has been widely used in photodynamic therapy due to their 
good water solubility and high efficiency in generating molecular singlet 
oxygen.11 However, RB has a relatively small TPA cross section (21 GM based on 
our measurements) and its application in two-photon PDT is limited. The 
absorption spectrum of RB overlaps well with the emission spectra of both PFE 
and PFV, as shown in Figure 3b. PFE and PFV can thus be used as light 
harvesting complexes to improve the one-photon and two-photon excitation 
efficiency of RB via FRET.  
The one-photon emission spectra of polymers/RB systems were measured to 
examine the FRET efficiency and one-photon optical amplification effects of the 
systems. The measurements were carried out in the PBS buffered (25 mM, pH = 
7.4) solutions with a fixed RB concentration (2.5×10-8 M) and increasing 
concentration of polymers. The anionic RB can form a complex with cationic 
polymers via electrostatic interactions to bring the energy donor and acceptor into 
close proximity to ensure efficient FRET. As shown in Figure 4, the emission 
intensity of RB gradually increases upon addition of cationic polymers, indicating 
efficient FRET from the polymers to RB. Under excitation at the maximum 
absorption of polymers (385 nm for PFE and 435 nm for PFV), the emission 
intensity of RB at 580 nm (I1) was found to be significantly enhanced compared 
to that when RB was directly excited at its absorption maximum at 540 nm (I0). 
The RB emission was found to be enhanced by up to 13-fold upon addition of 
PFE, and about 15-fold upon addition of PFV. The slightly different enhancement 
factor by PFE and PFV are consistent with slightly larger absorption coefficient 
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(ε) of PFV compared to that of PFE. These results confirmed efficient FRET from 
the cationic conjugated polymers to the photosensitizer, RB. The one-photon 
excitation capability of RB can be significantly enhanced by using these CCPs as 
light harvesting complexes. 
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Figure 2.3  (a) Chemical structure of photosensitizer Rose Bengal; (b) absorption 
spectrum of  RB and emission spectra of PFE and PFV. 
 


















































Figure 2.4  (a) Emission spectra of RB/PFE complex upon gradual addition of 
PFE into PBS buffered RB solution (25mM, pH=7.5): [PFE]= 0~2.8×10-6 M in 
repeat units, [RB]= 2.5×10-8 M), λEX = 385 nm; (b) Emission spectra of RB/PFV 
complex upon gradual addition of PFV into PBS buffered RB solution (25mM, 
pH=7.5): [PFV]= 0~2.8×10-6 M in repeat units, [RB]= 2.5×10-8 M, λEX = 435 


































































































Figure 2.5  (a) Two-photon excitation emission spectra of PFE/RB complex upon 
gradual addition of PFE into the RB solution in PBS buffer (25 mM, pH = 7.5), 
[PFE] = 0~2.0×10-6 M in repeat units; (b) two-photon excitation emission spectra 
of PFV/RB complex upon gradual addition of PFV into the RB solution in PBS 
buffer (25mM, pH =7.5): [PFV] = 0~2.8×10-6 M in repeat units; Insets are the 
plot of enhancement factor of RB emission versus polymer concentration; (c) 
Two-photon excitation emission spectra of  PFE, PFE/RB complex,  RB, and RB 
amplified 48 times, [PFE] = 1.2×10-6 M in repeat units; (d) two-photon excitation 
emission spectra of PFV and RB alone and PFV/RB complex, [PFV] = 2.8×10-6 
M in repeat units. [RB] = 2.5×10-8 M in all samples. All two-photon experiments 
were performed under excitation at 800 nm. 
 
2.3.4  Two-photon excitation fluorescence resonance energy transfer (TPE-
FRET)  
The two-photon excitation fluorescence assays were similarly examined by adding 
cationic polymers into the RB solution (2.5×10-8 M). The samples were excited 
with femtosecond laser pulses with a central wavelength at 800 nm and pulse 
duration of 40 fs. As can be seen from Figure 5, the intensities of two-photon 
excitation emission of RB were significantly enhanced upon gradual addition of 
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the polymers (PFE or PFV) into the RB solution until saturation. The 
enhancement factor (the ratio of RB emission intensity in the presence of the 
polymers over that in the absence of the polymers) as a function of polymer 
concentration is plotted in Figure 5. The two-photon emission of RB was 
enhanced by up to about 20 times by addition of PFE, and more than 85 times by 
addition of PFV, respectively. 
The observed large enhancement factors via TPE-FRET is mainly due to larger 
TPA cross sections of the conjugated polymers at 800 nm compared to that of RB 
(see data in Table 2), owing to improved conjugation lengths of the conjugated 
polymers. In addition, conjugated polymers are made of many repeat units or 
conjugation segments, the excitation energy harvested by the entire polymer chain 
can migrate along the polymer chain39 and eventually transfer to bound RB 
molecules via FRET, which result in optical amplification as in the one-photon 
excitation case. Both factors are responsible for the observed large enhancement 
in the two-photon excitation emission of the RB molecules. 
Under one-photon excitation, addition of PFE and PFV resulted in similar 
magnitudes of enhancement in the emission intensities of RB, which is consistent 
with similar absorption coefficients (ε) of PFV and of PFE.  However, addition of 
PFE and PFV result in quite different magnitudes of enhancement in two–photon 
excitation emission of RB. The enhancement factor when using PFV as the two-
photon light harvesting complex is about 4.5 times that when using PFE as the 
two-photon light harvesting complex. This different enhancement factors are 
consistent with the relative TPA cross sections of PFE and PFV at 800 nm (Table 
2). The inherent two-photon property of CCPs is the primary factor for their 
amplification ability. The difference in other factors, such as quantum yield of 
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polymers, polymer chain length and energy transfer efficiency are also partially 
responsible for the observed different enhancement factors. To further design 
efficient system for application in two-photon photodynamic therapy and multi-
photon imaging, it is essential to design conjugated polymers with large TPA 
cross sections at 800 nm as two-photon light harvesting complexes. 
 
2.3  Conclusion 
In summary, two new water-soluble conjugated polymers, PFE and PFV, have 
been designed and synthesized to act as two-photon light harvesting complexes to 
amplify the two-photon property of water-soluble photosensitizers and organic 
dyes through FRET. The TPA cross sections at 800 nm have been significantly 
improved by inserting the vinylene and ethynylene groups as the bridges, which 
extend the conjugation length. The TPA cross section (per repeat unit) of PFV 
(with a vinylene bridge) at 800 nm is 4.5 times than that of PFE (with an 
ethynylene bridge), and 36 times than that of PFP. The two-photon excitation 
emission of the photosensitizer RB was found to be significantly enhanced 
through FRET by using these conjugated polymers as two-photon light harvesting 
complexes. The two-photon emission of RB was enhanced by up to about 20 
times when PFE was used and more than 85 times when PFV was used, 
respectively. The inherent two-photon property of CCPs is believed to be the 
primary factor responsible for the observed huge enhancement in the two-photon 
emission of the photosensitizer. These studies are expected to provide insight on 
designing systems with further improved performance for potential applications in 
two-photon PDT, sensing and imaging. 
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Enhanced two-photon singlet oxygen generation by 
photosensitizer-doped conjugated polymer nanoparticles 
 
3.1  Introduction 
Singlet oxygen, which causes cell death by apoptosis, plays a key role in 
photodynamic therapy (PDT).1 In PDT, a photosensitizer is photo-excited to be 
promoted onto the singlet excited state followed by formation of the triplet state 
via intersystem crossing. The photosensitizer in the triplet excited state finally 
transfers its energy transfer to the ground state oxygen (3O2 ), resulting in the 
generation of singlet oxygen (1O2) which is known to cause irreversible damage to 
nucleic acids, enzymes, and other cellular components and lead to cell death. 
Porphyrin-based derivates are widely used as photosensitizers for singlet oxygen 
generation, whose main absorption band is in the range of 400-600 nm. As lights 
in 400-600 nm have very limited penetration into the tissues, PDT is generally 
limited to treating superficial tumors (e.g. skin, esophagus, and bladder, etc.).2 
Two-photon absorption (TPA) of photosensitizers enables excitation light shift 
to longer wavelengths in the near-infrared region between 750-1000 nm, which is 
coincident with tissue transparency window. It enables increased light penetration 
depth into living tissues.3 Furthermore, as two-photon absorption is quadratically 
dependent on laser intensity, two-photon PDT allows 3-dimensional selectivity to 





Porphyrins have been widely used as photosensitizers for photodynamic therapy.4 
However, their small TPA cross-sections (σ: 1-50 GM; 1 GM = 10-50 
cm4·s·photon-1)5 limit their efficiency in the generation of singlet oxygen by two-
photon excitation. 
One method to improve the efficiency of two-photon PDT is to synthesize new 
photosensitizers6 or chemical modification of porphyrins7 to improve TPA cross-
sections and maintain efficient singlet oxygen generation, but this is complicated 
and time-consuming. Alternatively, resonance energy transfer from materials with 
large TPA cross-sections to photosensitizers could be utilized to enhance the 
singlet oxygen generation efficiency by two-photon excitation.8-11 Different 
approaches have been demonstrated, such as using porphyrin-core dendrimers,8 
block copolymer micelles,9a-b silica nanoparticles,9c and Quantum dot-
photosensitizer conjugates.11 However, these methods generally involve 
sophisticated chemical synthesis. 
Conjugated polymers have large delocalized π-conjugated backbones and are 
known to have large extinction coefficients and TPA cross-sections. They display 
optical amplification by resonance energy transfer.12 This feature has been widely 
utilized to develop various bio-sensing and imaging schemes with enhanced 
detection efficiency.13-14 The large TPA cross-sections of conjugated polymers15,16 
have also been utilized in two-photon light-harvesting complexes to improve two-
photon excitation emission of dyes and photosensitizers in the electrostatic 





conjugated polymers have been demonstrated to have good biocompatibility with 
low cytotoxicity,18 which makes them promising materials for biological and 
medical applications. 
In this work, we have prepared photosensitizer-doped conjugated polymer 
nanoparticles aqueous dispersion: poly[9,9-dibromohexyl fluorene-2,7-
ylenethylene -alt-1,4-(2,5-dimethoxy) phenylene] (PFEMO) doped with 
tetraphenylporphyrin (TPP). In the nanoparticles, PFEMO serves as the hosting 
material and energy donor and TPP serves as a guest and energy acceptor. The 
energy transfer from PFEMO to TPP helps to enhance the efficiency of singlet 
oxygen generation. Enhanced two-photon excitation TPP emission and singlet 
oxygen generation efficiency in the TPP-doped PFEMO nanoparticles have been 
demonstrated. These results demonstrated that photosensitizer-doped conjugated 
polymer nanoparticles could be potentially useful in two-photon photodynamic 
therapy. 
 
3.2  Experimental section 
Materials: Tetraphenylporphyrin (TPP), 9,10-anthracenediyl bis(methylene) 
dimalonic acid (ABDA), deuterium oxide and tetrahydrofuran (THF) were 
purchased from Sigma Aldrich. 
Synthesis of 2,7-bis[(trimethylsilyl)ethynyl]-9,9-di(6’-bromohexy) fluorine (1): 
2,7-Diiodo-9,9-di(6’-bromohexy)fluorine was prepared according to a previously 





2 mmol), copper iodine (80 mg, 0.42 mmol) and triethylamine (2 mL, 14 mmol) in 
20 mL of THF were stirred under N2 for 30 min. Trimethylsilyl acetylene (490 mg, 
5mmol) and Pd(PPh3)2Cl2 (50 mg, 0.072 mmol) were then added and the mixture 
were stirred for 24h at room temperature. After removing the solvent in vacuum 
and purified by passing through a silica gel column using DCM/Hexane=1:10 as 
the eluent, a yellow solid product (800 mg, 59%) was obtained. The NMR and 
mass spectra results are: a) 1H NMR (300MHz, CDCl3): δ 7.59 (d, 2H), 7.46 (d, 
2H), 7.41(s, 2H), 3.28(t, 4H), 1.97-1.91(m, 4H), 1.70-1.60(m, 4H), 1.16-1.08(m, 
8H), 0.53(m, 4H), 0.29(s, 18H); b)  13C NMR (300MHz, CDCl3): 150.5, 140.8, 
131.4, 126.1, 121.9, 119.9, 105.9, 94.5, 55.1, 40.2, 33.9, 32.7, 29.0, 27.8, 23.4, 
0.04; c) MS (EI): m/z= 685 (M+). 
Synthesis of 2,7-diethylnyl-9,9-di(6’- bromohexy)fluorine (2): 2,7-Bis 
[(trimethylsilyl)ethynyl]-9,9-di(6’-bromohexy) fluorine (680 mg, 1 mmol) and 
potassium carbonate (1.38 g, 10 mmol) were mixed into 50 mL of methanol and 
the solution was stirred overnight at room temperature. Then the solvent was 
stripped off under reduced pressure. The residue was dissolved into 100 mL of 
chloroform. The organic solution was washed successively with 1.0 M aqueous 
HCl and water, and then dried over anhydrous MgSO4. A yellow oil product (460 
mg, 95%) was obtained after the solvent was removed. The NMR and mass 
spectra results are: a) 1H NMR (300MHz, CDCl3): δ 7.62 (d, 2H), 7.49 (d, 2H), 
7.45(s, 2H), 3.28(t, 4H), 3.16(s, 2H), 1.98-1.92(m, 4H), 1.68-1.61(m, 4H), 1.16-





131.4, 126.5, 120.9, 120.0, 72.7, 58.4, 55.1, 40.2, 33.9, 32.7, 29.0, 27.8, 23.6; c) 
MS (EI): m/z= 540 (M+). 
Synthesis of poly[9,9-dibromohexylfluorene-2,7-ylenethylene-alt-1,4-(2,5- 
dimethoxy) phenylene] (PFEMO): 1,4-dibromo-2,5-dimethoxy phenylene (148 
mg, 0.5 mmol), 2,7-Diethylnyl-9,9-di(6’- bromohexy)fluorine (270 mg, 0.5 mmol), 
Pd(PPh3)2Cl2 (50 mg, 0.072 mmol) and cuprous iodide(19.2 mg, 0.1 mmol) were 
combined in degassed toluene (10mL) and diisopropylaine (4 mL). The reaction 
mixture was stirred at 70℃ for 24h. After cooling to the room temperature, the 
solvent was removed under vacuum. The residue was dissolved into 50 mL of 
chloroform and washed with water. The organic layer was dried over with MgSO4, 
and then precipitated in methanol. The precipitate was filtered off and re-
precipitated twice in methanol to afford a brown solid product (195 mg, 58%). 1H 
NMR (300MHz, CDCl3): δ 7.72(br, 2H), 7.58-7.49(br, 8H), 3.74(s, 6H) 3.26(br, 
4H), 2.08(br, 4H), 1.63-1.55(br, 4H), 1.15-1.07(br, 8H), 0.65(br, 4H); GPC: 
Mw=26704, PDI=2.45. 
Preparation of TPP doped PFEMO nanoparticles: TPP-doped PFEMO 
nanoparticles were prepared by using a modified re-precipitation method.19 
Different amount of TPP solution in THF (0.1 mM) were mixed with 2.0 mL of 
PFEMO stock solution in THF (40 μM). The mixtures were added quickly into 8 
mL deionized water under sonication. Clear Yellow-green color nanoparticles 
dispersion was obtained after THF was removed by vacuum evaporation. 





AC Bruker spectrometers. Mass spectra were measured by using an AEI-M850-
MS spectrometer. GPC analysis was carried out on a Waters Styragel system using 
polystyrene as the calibration standard and tetrahydrofuran (THF) as eluent. The 
UV-Vis absorption and fluorescence spectra were measured by using a Shimadzu 
UV-vis spectrophotometer and a Jobin-Yvon Fluoromax-4 sepctrofluorometer, 
respectively. The morphology of the nanoparticles was measured by using an 
Ambios Q250 multimode atomic force microscopy (AFM). In an AFM 
measurement, one drop of the nanoparticles dispersion was placed on a freshly 
cleaved mica substrate and scanned in a tapping mode after evaporation of the 
water. 
Two-photon excitation fluorescence measurements: Two-photon excitation 
fluorescence (TPEF) measurements were performed by using a Spectra Physics 
femtosecond Ti:sapphire oscillator (Tsunami) as the excitation source. The output 
laser pulses have a central wavelength at 800 nm with pulse duration of 40 fs and 
repetition rate of 80 MHz. The laser beam was focused onto the samples that were 
contained in a cuvette with path length of 1 cm. The emission from the samples 
was collected at a 90º angle by a pair of lenses and an optical fiber that was 
connected to a monochromater (Acton, Spectra Pro 2300i) coupled with CCD 
(Princeton Instruments, Pixis 100B) system. A short pass filter with a cutoff 
wavelength at 750 nm was placed before the spectrometer to minimize the 
scattering from the pump beam. 





directly monitored by the luminescence of singlet oxygen. Singlet oxygen has 
luminescence at ~1275 nm in D2O dispersion, which was monitored by using a 
Fluorolog-3 iHR spectrafluorometer (Jobin-Yvon) equipped with a NIR sensitive 
photomultiplier (Hamamatsu model: R5509-72) operated at -80 ºC. An 850 nm 
long-pass filter was placed before the detector. 
Two-photon induced singlet oxygen generation was monitored by chemical 
oxidation of ABDA in the nanoparticles water dispersions. The decrease in the 
ABDA absorbance was monitored under irradiation with femtosecond laser pulses 
at 800 nm. The sample solution was prepared by combing 1.0 mL of the 
nanoparticles dispersions in water with 0.1 mL of ABDA stock solution in water 
(0.5 mM). The laser beam was focused onto a cuvette (1 cm pathlength and 2 mm 
width) containing 0.5 mL solution. 
 
3.3  Results and discussions 
3.3.1 Preparation and nanoparticles and characterization  
The conjugated polymer, PFEMO, was synthesized by using a Sonogashira 
Coupling polymerization method (Scheme 3.1).20 The molecular weight (Mw) was 
measured to be 26704 with Mw/Mn is 2.45 by GPC, which is equivalent to ~40 
repeat units. PFEMO was chosen as the doping host and energy donor. TPP was 
selected as photosensitizing acceptor because its Soret and Q bands overlap well 
with the emission spectrum of PFEMO (Figure 3.1). TPP-doped PFEMO 





addition of a solution of PFEMO and TPP in THF into water under sonication led 
to collapse of polymer chains, which results in formation of nanoparticles and 
simultaneous entrapment of the hydrophobic TPP molecules inside the 
nanoparticles. The obtained nanoparticles dispersions are yellow-green in color. 
The particles dispersions are stable for more than one week without any 
precipitation. The AFM measurements on TPP-doped PFEMO nanoparticles 
indicated that the obtained particles are nearly spherical in shape with particles 
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Figure 3.1  (a) Schematic illustration of the formation of conjugated polymer 
nanoparticles for two-photon PDT. (b) Normalized absorption and emission of 






3.3.2 Absorption and fluorescence properties 
The UV spectra of TPP-doped nanoparticles showed an increase in the absorption 
peak at about 419 nm and a weak broad band from 500 to 600 nm with increasing 
doping amount of TPP (1% to 7%, molar ratio of [TPP]/[PFEMO Repeating 
Unit]), which are due to Soret band and Q band of TPP, respectively (Figure 3.2a). 
The excitation wavelength was chosen at 387 nm to selectively excite PFEMO 
and avoid direct excitation of TPP. As can be seen from Figure 3.2b, fluorescence 
of PFEMO in the range 400-600 nm were quenched compared to non-doped 
PFEMO NPs. A new emission band centered at ~652 nm appeared, which is due 
to energy transfer from FPEMO to TPP.  
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Figure 3.2  (a) Absorption and (b) fluorescence spectra of various TPP doped 
PFEMO nanoparticles. λex = 387 nm. 
 
    Compared to the same amount of TPP in water dispersion under excitation at 
417 nm, the doped PFEMO nanoparticles showed a 2-fold enhancement in TPP 
emission for 1% TPP doped nanoparticles (Figure 3.3a). The emission 





have a larger light absorption capability. However, no amplification of TPP 
emission was observed for 3% and 7% TPP doped PFEMO nanoparticles (Figure 
3.3b-c). The reduced enhancement factor at higher TPP doping concentration is 
because the number of PFEMO molecules (donor) per TPP molecules (acceptor) 
becomes smaller. Consequently less donor molecules contribute to absorbing the 
light to transfer the harvested energy to the acceptor, which will result in reduced 
enhancement factor.  Another reason might be due to self-aggregation of TPP 
molecules at higher doping concentrations, which will decrease their fluorescence 
efficiency. 
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(a)                                      (b)                   (c)
Figure 3.3  The emission spectra of (a) 1%, (b) 3%, and (c) 7% TPP-doped 
PFEMO nanoparticles (λex = 397 nm) and same amount of TPP water dispersion 
(λex = 417nm). 
 
3.3.3 Two-photon excitation emission 
Figure 3.4 shows two-photon excitation emission spectra of the TPP doped 
PFEMO nanoparticles under irradiation with femtosecond laser pulses at 800 nm. 
Under two-photon excitation, the pure TPP in water dispersions displayed a weak 
emission at ~652 nm due to small TPA cross-sections of the TPP molecules. In 





nanoparticles was significantly enhanced, by a factor of about 21, 10.3 and 4.5 for 
1%, 3% and 7% TPP-doped PFEMO nanoparticles, respectively. The observed 
amplification in two-photon excitation fluorescence is due to a large difference 
between the TPA cross sections of PFEMO and TPP.9c   
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Figure 3.4  Two-photon excitation emission of TPP doped PFEMO nanoparticles 
with different doping concentrations (1%, 3% and 7%) and the same amount of 
pure TPP in water dispersion. λex: 800 nm. 
 
The enhancement factor for one-photon and two-photon excitation can be 
estimated based on the photo-physical parameters of the donor and acceptors. We 
have estimated the theoretical enhancement factor under one- and two-photon 
excitation for 1% TPP-doped PFEMO nanoparticles. The molar coefficient of 
PFEMO and TPP are 6.6x104 and 2.67x105 L.mol-1.cm-1, respectively.21 The 





FRET efficiency was calculated to be 78% for 1% TPP-doped PFEMO 
nanoparticles. The one-photon excitation emission enhancement factor can be 
estimated to be (6.6 × 104 × 0.08 × 100 × 78%)/(2.67× 105) = 1.5. The value is 
quite close to the experimental value of 2.0. The minor discrepancy between the 
experimental and calculation values might be due to the inaccuracy in the QY 
measurements of PFEMO or the change in the QY of PFEMO upon incorporation 
of TPP that may reduce self-aggregation of PFEMO in the nanoparticles.  The 
TPA cross section of PFEMO was measured to be 2160 per molecule (54 GM per 
repeat unit). The TPA cross section of TPP was taken from the literature value of 
12 GM.5b The two-photon excitation emission enhancement factor can be 
estimated to be (54 × 100 × 0.08 × 78%)/12= 28. This estimated value is quite 
close to the experimental result (21-folds) for 1% TPP-doped PFEMO 
nanoparticles. The minor discrepancy between the experimental and calculation 
values might be due to inaccuracy in determining the values of TPA cross sections. 
 
3.3.4 Singlet oxygen generation 
We have assessed the singlet oxygen generation capability of TPP-doped PFEMO 
nanoparticles by monitoring the singlet oxygen luminescence under one-photon 
excitation. As the singlet oxygen luminescence in water is difficult to measure due 
to its short lifetime (~3.5 μs) and low emission yield, D2O was used as the 
dispersion solvent instead. The luminescence lifetime of singlet oxygen in D2O 





shown in Figure 3.5, the characteristic singlet oxygen emission with a peak at ~ 
1275 nm was clearly observed for the TPP-doped PFEMO nanoparticles under 
excitation at 397 nm, indicating efficient singlet oxygen generation. Compared to 
TPP in D2O dispersion under excitation at 417 nm, about 2-fold enhancement of 
singlet oxygen emission was observed in 1% TPP-doped PFEMO nanoparticles, 
which is consistent with the corresponding enhancement of TPP emission. These 
results confirm that conjugated polymer PFEMO could act as a light-harvesting 
complex to enhance the photosensitizing efficiency of TPP by energy transfer. 
Similarly, consistent with the one-photon excitation emission results, no 
enhancement in the singlet oxygen generation for 3% and 7% TPP-doped PFEMO 
nanoparticles was observed. 
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 Figure 3.5 Emission of singlet oxygen generated by (a) 1%, (b) 3% and (c) 7% 
TPP doped PFEMO nanoparticles as well as same amount of TPP dispersions in 
D2O. 
 
Two-photon induced singlet oxygen generation was evaluated by using a 
chemical method based on the oxidation of 9,10-anthracenediyl-bis(methylene) 
dimalonic acid (ABDA).23 In this method, ABDA can be oxidized in presence of 





absorption. Figure 3.6 shows the ABDA oxidation in water in the presence of 
TPP-doped PFEMO nanoparticles under the irradiation of femtosecond laser 
pulses at 800 nm. TPP water dispersion and pure PFEMO nanoparticles dispersion 
in water were also employed as controls in the experiment. As shown in Figure 
3.6a, the ABDA absorption decreased continuously over the course of irradiation 
in the presence of TPP-doped PFEMO nanoparticles. In contrast, the decrease in 
ABDA absorption is much less and slower in the control experiments. The photo-
oxidation rate constants of ABDA in the presence of TPP-doped PFEMO NPs, 
pure PFEMO NPs and TPP water dispersion were calculated to be 1.7×10-3 min-1, 
1.07×10-4 min-1, and 2. 62×10-4 min-1, respectively. The photo-oxidation rate for 
TPP-doped PFEMO NPs was 15.9-fold faster than that for pure PFEMO NPs and 
6.5-fold faster than that for TPP water dispersion. These results gave unambiguous 
evidence that the energy transfer from PFEMO to TPP significantly enhanced the 
capability of two-photon excitation singlet oxygen generation of TPP.  
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 Figure 3.6  (a) Photo-oxidation of ABDA by singlet oxygen generated from 
PFEMO 1% TPP nanoparticles in water under two-photon excitation at 800 nm. (b) 
Comparison of ABDA oxidation in 1% TPP, PFEMO, and PFEMO 1% TPP 






3.4  Conclusion  
Photosensitizer-doped conjugated polymer nanoparticles using PFEMO as hosting 
materials and TPP as energy acceptor have been prepared by using a re-
precipitation method. These nanoparticles are stable and have a uniform size of 
~50 nm. Efficient intra-particle energy transfer from PFEMO to TPP has been 
observed. Although there was only mild enhancement (up to 2 folds) in the TPP 
emission of the nanoparticles under one-photon excitation, the two-photon 
emission of TPP was found to be significantly enhanced by up to 21 folds in the 
nanoparticles. The larger TPA cross section of conjugated polymers and efficient 
energy transfer from PFEMO to TPP helps to enhance the efficiency of singlet 
oxygen generation under two-photon excitation. Enhanced two-photon excitation 
singlet oxygen generation efficiency in the TPP doped PFEMO nanoparticles has 
been demonstrated. Our results suggest that these photosensitizer-doped 
conjugated polymer nanoparticles can act as novel photosensitizing agents for 
two-photon photodynamic therapy and related applications. 
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Photosensitizer-doped conjugated polymer nanoparticles for 
simultaneous two-photon imaging and two-photon 
photodynamic therapy in living cells 
 
 
4.1  Introduction 
Photodynamic therapy (PDT) is a well-established clinical treatment method for 
cancer and other diseases.1,2 In PDT, photosensitizer is promoted onto the singlet 
excited state by absorption of light, followed by formation of the triplet excited 
state via intersystem crossing. The photosensitizer in the triplet state subsequently 
transfers its energy to the ground state oxygen (3O2), resulting in generation of 
singlet oxygen (1O2) that is known to cause irreversible damages to nucleic acids, 
enzymes, and other cellular components and lead to cell death by apoptosis.3 
 The application of conventional PDT is hindered by limited light penetration 
depth into tissues in the visible range and lack of selectivity in the z-direction.4 
Two-photon PDT is one of promising approaches to increase light penetration into 
tissues as it uses excitation sources of longer wavelengths that fall within the 
tissue transparency window (750 to 1100 nm).5 It also allows 3-dimensional 
selectivity to precisely target tumor cells and prevents damages to nearby healthy 
tissues. However, most porphyrin based photosensitizers currently used in clinical 
treatments have very small two-photon absorption (TPA) cross-sections (1-50 
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GM; 1 GM = 10-50 cm4·s·photon-1), which limits their effectiveness in two-photon 
PDT.6, 7 To improve the two-photon properties of the photosensitizers, energy 
transfer from a molecule with a large TPA cross section to the photosensitizers 
has been utilized.8-12  Several recent efforts on nanoparticles-based 
photosensitizers were developed by introducing materials with large TPA cross 
sections into nanoparticles to enhance two-photon excitation properties of the 
conventional photosensitizers.13-16 Bio-conjugated nanoparticles based 
photosensitizers allow further improved selectivity for cancerous tissues.2, 17, 18 
 Conjugated polymers receive lots of attention due to their large one- and two-
photon absorption coefficients, high fluorescence quantum yields and 
fluorescence amplification by energy transfer.19-32 Recently, water-dispersible 
conjugated polymer nanoparticles have been successfully prepared by mini-
emulsion and re-precipitation methods.33-35 They have emerged as new ultra-
bright fluorescent probes for biological imaging under one- and two-photon 
excitation.36-42 In addition, conjugated polymer nanoparticles constructed by 
blending two polymers or doping with specific dyes can be tuned to alter their 
excitation and emission properties.43-46 Conjugated polymers with large TPA cross 
sections have been utilized as two-photon light-harvesting materials to enhance 
two-photon excitation emission of dyes or photosensitizers and as well as two-
photon excitation singlet oxygen generation.47-50  
 Here we report the preparation of photosensitizer-doped conjugated polymer 
nanoparticles with enhanced singlet oxygen generation efficiency and efficient 
photodynamic therapy activity in living cells. The nanoparticles were prepared by 
incorporating non-ionic surfactant, polyoxyethylene nonylphenylether (CO-520), 
into tetraphenylporphyrin (TPP) doped poly[9,9-dibromohexyl fluorene-2,7-
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ylenethylene-alt-1,4(2,5-dimethoxy phenylene] (PFEMO) nanoparticles (CO-T-P 
NPs). The conjugated polymer, PFEMO, serves as the hosting material and two-
photon light harvesting complex. The enhanced singlet oxygen generation under 
one- and two-photon excitation has been demonstrated. These nanoparticles were 
found to display very low cytotoxiticy in dark. The uptake of these nanoparticles 
in living cancer cells has been mapped by two-photon excitation fluorescence 
imaging. These nano-photosensitizers have also been demonstrated to display 
significantly enhanced two-photon photodynamic activity on cancer cells. 
 
4.2 Experimental section 
Materials: Tetraphenylporphyrin (TPP), polyoxyethylene nonylphenylether (CO-
520), 9, 10-anthracenediyl bis(methylene) dimalonic acid (ABDA), deuterium 
oxide and tetrahydrofuran (THF) were purchased from Sigma Aldrich. Dulbecco's 
modified eagle medium (DMEM), fetal bovine serum, streptomycin, penicillin, 
phosphate buffered saline (PBS) buffer solution, and 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer solution were purchased from 
Invitrogen. Poly[9,9-dibromohexyl fluorene-2,7-ylenethylene -alt-1,4-(2,5-
dimethoxy) phenylene] (PFEMO) was synthesized as described in the literature.49 
The molecular weight (Mw) was measured to be 26704 with Mw/Mn of 2.45.  
Preparation of CO-520 incorporated TPP doped PFEMO nanoparticles (CO-
T-P NPs): CO-T-P NPs were prepared by using a modified re-precipitation 
method.33 8.0 μL of TPP solution in THF (0.1 mM) were mixed with 2.0 mL of 
PFEMO stock solution in THF (40 μM) with or without 8.0 μL of CO-520 
solution in THF (2mM). The mixtures were quickly added into 8 mL deionized 
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water under sonication. THF was then removed by vacuum evaporation. The 
relative ratios of different components were determined by the molar ratio of the 
starting materials. After preparation of the nanopartciles, the nanoparticles were 
centrifuged out and the absorption and emission spectra of the supernatant liquid 
were measured. No signal from TPP and PFEMO were observed, which suggest 
that all PFEMO and TPP molecules were incorporated into the nanoparticles.  
Characterizations: The UV-Vis absorption and fluorescence spectra were 
measured by using a Shimadzu UV-Vis spectrophotometer and a Jobin-Yvon 
Fluoromax-4 spectro-fluorometer, respectively. The morphology of the 
nanoparticles was characterized by using an Ambios Q250 multimode atomic 
force microscopy (AFM). In an AFM measurement, one drop of the nanoparticle 
dispersion was placed on a freshly cleaved mica substrate and scanned in a 
tapping mode after evaporation of the water. The size distribution of the 
nanoparticles was measured by dynamic light scattering (DLS) (Zetasizer Nano 
ZS, Malvern).  
Two-photon excitation fluorescence (TPEF) measurements: TPEF 
measurements were performed by using a Spectra Physics femtosecond 
Ti:sapphire oscillator (Tsunami) as the excitation source. The output laser pulses 
have a central wavelength at 800 nm with pulse duration of 40 fs and repetition 
rate of 80 MHz. The laser beam was focused onto the sample that was contained 
in a cuvette with a path length of 1 cm. The emission from the sample was 
collected at an angle of 90 degrees to the incoming excitation beam by a pair of 
lenses and an optical fiber that was connected to a monochromater (Acton, 
Spectra Pro 2300i) coupled CCD (Princeton Instruments, Pixis 100B) system. A 
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short pass filter with a cutoff wavelength at 750 nm was placed before the 
spectrometer to minimize the scattering from the pump beam. 
Detection of singlet oxygen generation: One-photon induced singlet oxygen 
generation was directly monitored by the luminescence of singlet oxygen at ~1275 
nm in D2O dispersion.  The singlet oxygen luminescence was measured by using a 
Fluorolog-3 iHR spectro-fluorometer (Jobin-Yvon) equipped with a near-infrared 
photomultiplier (Hamamatsu model: R5509-72) operated at -80 ºC. An 850 nm 
long-pass filter was placed before the detector. 
Two-photon excitation singlet oxygen generation was monitored by chemical 
oxidation of ABDA in the presence of nanoparticle dispersion. The oxidation of 
ABDA by the generated singlet oxygen caused a decrease in the ABDA 
absorption,52 which was monitored under irradiation with femtosecond laser 
pulses at 800 nm. The sample solution was prepared by combing 1.0 mL of the 
nanoparticle dispersions in water with 0.1 mL of ABDA stock solution in water 
(0.5 mM). The laser beam was focused onto a cuvette (1 cm path length) 
containing the sample solution. 
Cell culture: The human hepatocellular carcinoma cell line HepG2 was cultured 
in the growth media (DMEM supplemented with 10% fetal bovine serum, 100.0 
mg/L streptomycin, and 100 IU/mL penicillin). Cells were maintained in a 
humidified atmosphere of 5% CO2 at 37 °C. 
Cell viability assay: Cell viability was determined by using the XTT colorimetric 
cell proliferation kit (Roche) following the manufacturer’s guidelines. Briefly, 
cells were grown to 20-30% confluence in 96-well plates. The medium was 
aspirated, washed with PBS, and then treated with 0.1 mL of the media containing 
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different amounts of the NPs. After 24 h incubation, cells were washed 4 times 
using PBS to remove excessive nanoparticles. Proliferation was assayed by using 
the XTT colorimetric cell proliferation kit (read at A460nm-A650nm). A total of three 
replicas were performed.  
Cell imaging: HepG2 cancer cells were seeded on glass-bottom dishes (Mattek) 
and grown until 70~80% confluence. The nanoparticles were added into the media 
and incubated for overnight. After washing four times with the PBS buffer 
solution, HEPES buffer-containing media were added. The cell imaging was taken 
by using a Leica TCS SP5X confocal microscope system equipped with a water 
immersion objective (Leica HCX PL APO 63x/1.20 W CORR CS). A 405 nm 
diode laser and a Ti-Sapphire oscillator at 800 nm were used as one-photon and 
two-photon excitation sources, respectively. A non-descanned detector (NDD) 
was used for the detection of two-photon fluorescence. Images were processed by 
using Leica Application Suite Advanced Fluorescence (LAS AF) software.  
Two-photon photodynamic therapy activity on cancer cells: HepG2 cancer 
cells were grown to 20-30% confluence in a 96-well plate. The medium was 
aspirated, washed with PBS, and then treated with 0.1 mL of the media containing 
the nanoparticles. After incubation overnight in dark, cells were washed 4 times 
using PBS to remove excessive NPs and re-cultured in a serum-containing 
DMEM medium. Each well was exposed to fs laser illumination at 800 nm with 
light doses from 0 to 630 J·cm-2. Cells after PDT treatments were further 
incubated for 24 h for apoptosis, and XTT was used assay the cell proliferation. 
Cell experiments without nanoparticles under the same condition were performed 




4.3  Results and discussion 
4.3.1 Preparasion and characterization of nanoparticles 
The conjugated polymer, PFEMO (Mw = 26704, Mw/Mn = 2.45, ~40 repeat 
units), was chosen as the doping host and energy donor. Its chemical structure is 
shown in Figure 4.1a. The TPA cross section was measured to be 2160 GM per 
molecule (54 GM per repeat unit) at 800 nm, the central wavelength of most 
readily available femtosecond laser source used in many applications. TPP was 
selected as the photosensitizing acceptor because its Soret and Q absorption bands 
overlap well with the emission spectrum of PFEMO (Figure 4.1b). The 
photosensitizer-doped conjugated polymer nanoparticles were prepared by 
incorporating non-ionic surfactant, polyoxyethylene nonylphenylether (CO-520), 
into TPP-doped PFEMO conjugated nanoparticles using a facile re-precipitation 
method. TPP and CO-520 were added into PFEMO solution in THF. Rapid 
addition of the mixture into water under sonication led to collapse of polymer 
chains and formation of TPP entrapped nanoparticles. The non-ionic amphiphilic 
surfactant was simultaneously incorporated onto the surface, leading to the 
hydrophilic polyoxyethylene portion stretching out into water (Figure 4.1a). The 
PFEMO conjugated polymer nanoparticles (CO-T-P NPs) were thus prepared.49 
The UV spectra of the CO-T-P NPs showed dominant absorption band at 390 nm 
and a weak absorption peak at about 419 nm, which originate from the PFEMO 
and Soret band of TPP (Figure 4.1b), respectively. Dynamic light scacttering 
(DLS) (Figure 4.2) measurements indicate that the average size of these CO-T-P 
nanoparticles is ~80 nm. The particle size measured from AFM measurements is 
~62.5 nm, slightly smaller compared to the DLS results, which is due to the 
shrinkage of the polymeric nanoparticles during sample drying processes and the 
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Figure 4.1  (a) Schematic illustration of the formation of conjugated polymer 
nanoparticles for two-photon photodynamic therapy; (b) Normalized absorption 
spectra of TPP, PFEMO and CO-T-P NPs (solid lines), and emission spectra of 
PFEMO (dash line); (c) AFM imaging of CO-T-P NPs on a mica substation. 
 
4.3.2 Stability of nanoparticles 
The stability of the nanoparticles in the PBS buffer solution is important for cell 
uptaking. It has been previously reported that cell uptaking of pure conjugated 
polymer nanoparticles without surface modification by cell was poor.40 The poor 
uptaking is most likely due to severe aggregation of nanoparticles in PBS and cell 
culture media. TPP-doped PFEMO NPs (T-P NPs) were previously reported to 
display good stability in water.49 However, they were found to severely aggregate 
in PBS buffer solution (Figure 4.2b). The aggregation is due to high ionic 
strength of the PBS buffer solution, which screens the weak surface charges and 
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reduces electrostatic repulsion between the nanoparticles in dispersion. The 
stability of the nanoparticles in the PBS buffer solution was significantly 
improved by incorporation of CO-520 (Figure 4.2d). The zeta potential of CO-T-
P NPs was -25.0 mV, which is slightly less negative than that of T-P NPs (-31.2 
mV). Incorporation of CO-520 leads to the hydrophilic polyoxyethylene chains on 
the nanoparticle surface, which protects the nanoparticles from aggregation even 
under high ionic strength. The resulting CO-T-P NPs were very stable and 
maintained almost the same size distribution in PBS buffer solution for more than 
two weeks without observation of any obvious aggregation or precipitation. These 
results confirm that the CO-520 incorporated, TPP-doped conjugated nanoparticle 






















































































Figure 4.2  Size distribution of unmodified nanoparticles T-P NPs (a) in distilled 
water and (b) PBS buffer solution; Size distribution of CO-T-P NPs (c) in distilled 




4.3.3 One-and two-photon optical properties 
    The one- and two-photon excitation emission spectra of the CO-T-P NPs with a 
molar ratio of PFEMO:TPP:CO-520=100:1:20 are shown in Figure 4.3. The 
excitation wavelength for one-photon excitation was chosen at 390 nm to 
selectively excite PFEMO and avoid direct excitation of TPP. The emission in the 
range 400-600 nm (Figure 4.3a) originates from PFEMO, while the emission 
band centered at ~652 nm is due to TPP. The intensity of the TPP emission 
showed a 2-fold enhancement compared to CO-T NPs under excitation at its 
absorption maxima at 417 nm. This amplification was due to energy transfer from 
the conjugated polymers that have a larger light absorption capability. Two-
photon excitation emission spectra of the nanoparticles under excitation at 800 nm 
using femtosecond laser pulses are shown in Figure 4.3b. The CO-T NPs only 
displayed a weak emission peak at 652 nm, due to the small TPA cross section of 
TPP. In contrast, the emission at 652 nm of the CO-T-P NPs containing the same 
amount of TPP was significantly enhanced by a factor of ~20 by energy transfer 
from PFEMO under two-photon excitation. The large amplification can be 
ascribed to the large difference of TPA cross sections between PFEMO and TPP 
(2160 GM for PFEMO and 12 GM for TPP respectively). Nanocompoistes with 
various proportion of host/guest molecules have been tested. The sample with a 
molar ratio of PFEMO:TPP=100:1 were found to give the largest  two-photon 
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Figure 4.3  (a) Emission spectra of CO-T-P NPs (with PFEMO, molar ratio of 
PFEMO:TPP:CO-520=100:1:20) and CO-T NPs (without PFEMO) under 
excitation at their individual absorption maximum (390 nm for CO-T-P NPs and 
417 nm for CO-T NPs); (b) Comparison of emission spectra of CO-T-P NPs  and 
CO-T NPs  under two-photon excitation at 800 nm. 
  
4.3.4 Singlet oxygen generation 
The singlet oxygen generation of the CO-T-P NPs was monitored by measuring 
the luminescence spectrum of singlet oxygen, which has a characteristic peak at 
~1272 nm. As the singlet oxygen luminescence in water is difficult to measure 
due to its short lifetime (~3.5 μs) and low emission yield, D2O was usually used as 
the dispersion solvent instead, which will extend its emission lifetime to 50~67 μs 
and significantly increase the emission yield of the singlet oxygen.51 As shown in 
Figure 4.4, the characteristic singlet oxygen emission at ~ 1272 nm was clearly 
observed for the CO-T-P NPs under excitation at 390 nm, indicating efficient 
singlet oxygen generation. Compared to CO-T NPs in D2O dispersion under 
excitation at 417 nm, about 2-fold enhancement of singlet oxygen emission was 
observed in CO-T-P nanoparticles, which is consistent with the corresponding 
enhancement of the TPP emission under one-photon excitation. These results 
further confirm that conjugated polymer PFEMO could act as an efficient light-
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Figure 4.4  Emission spectra of singlet oxygen generated by CO-T-P and CO-T 
NPs in D2O under one-photon excitation. 
    
    The ability of the nanoparticles to generate singlet oxygen under two-photon 
excitation at 800 nm was evaluated by monitoring the photo-oxidation of 9,10-
anthracenediyl-bis(methylene) dimalonic acid (ABDA).52  In this method, the 
ABDA absorption is bleached due to reaction with the singlet oxygen, which can 
thus be utilized to monitor singlet oxygen generation. As shown in Figure 4.5, the 
ABDA absorption between 340 and 420 nm decreased continuously over the 
course of irradiation in the presence of CO-T-P NPs. While in the case of 
nanoparticles containing CO-520 and TPP only (CO-T NPs) or CO-520 and 
PFEMO only (CO-P NPs), much less photobleaching of ABDA was observed 
under the same irradiation conditions. The photo-oxidation rate of ABDA in the 
presence of CO-T-P NPs is about 5 times faster than that in the presence of CO-T 
NPs. The significantly enhanced capability of two-photon singlet oxygen 
generation is mainly due to the larger TPA cross section of PFEMO compared to 
that of TPP. In CO-T-P NPs, PFEMO was more effectively excited under two-
83 
 
photon excitation and the excitation energy was then transferred to TPP, which 
subsequently underwent a series of photophysical processes to generate singlet 
oxygen. 







































Figure 4.5  (a) Photo-oxidation of ABDA by singlet oxygen generated from CO-
T-P NPs in water under two-photon excitation at 800 nm. (b) Comparison of 
ABDA oxidation in CO-T, CO-P and CO-T-P NPs in water as a function of 
irradiation time. 
 
4.3.5 Dark cytotoxicity of nanoparticles 
The cytotoxicity of the CO-T-P NPs without any light illumination was evaluated 
by monitoring the metabolic viability of HepG2 cells after incubation with CO-T-
P NPs. Figure 4.6b shows the cell viability after incubation with CO-T-P NPs at 
different concentrations (in terms of PFEMO repeat units) for 24 h in dark. The 
metabolic viability of the HepG2 cells nearly did not change after incubation with 
the CO-T-P NPs, even when the concentration of PFEMO was as high as 1.9 μM. 
The low cytotoxicity of CO-T-P NPs in dark ensures their applications in real 
practice. In contrast, the unmodified T-P NPs were found to show severe 
cytotoxicity under the same conditions  (Figure 4.6a). The cytotoxicity might 
arise from severe nanoparticle aggragation on the cell surface.53 The cytotoxicity 
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of the conjugated polymer nanoparticles in dark has been sufficiently reduced 
after incorporation of polyoxyethylene chains of CO-520, which prevents 
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Figure 4.6 Cell viability assay of HepG2 cancer cell treated with a) unmodified 
nanoparticles T-P NPs and b) CO-T-P nanoparticles ranged from 0 to 1.9 μM for 
24 h in dark.  
 
5.3.6 Two-photon exicitation fluorescence cell imaging 
The two-photon emission of the PFEMO could be utilized to evaluate the 
cellular uptake of the CO-T-P NPs. The two-photon excitation fluorescence 
imaging of living cancer cells using two-photon laser scanning confocal 
microscopy was performed under excitation at 800 nm with a 450-550 nm band 
pass emission filter. Figure 4.7 shows the two-photon excitation images of HepG2 
cancer cells after incubation with CO-T-P NPs for overnight. An intense green 
fluorescence signal was observed from the cells. By overlaying the transmission 
image and two-photon excitation fluorescence image, the CO-T-P NPs were found 
to mainly accumulate around the nuclear region, indicating that the CO-T-P NPs 
were actively taken up and internalized into the cells by endocytolysis.54 
We have also investigated the potential applications of the CO-T-P NPs as two-
photon photodynamic therapy agent. The cancer cells incubated with CO-T-P or 
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CO-T NPs were exposed under femtosecond laser irradiation at 800 nm with 
energy density of ~3.0 W·cm-2. The concentration of the CO-T-P NPs was 1.4 μM 
(PFEMO repeat units) and the concentration of CO-T NPs was maintained same 
as that of the CO-T-P NPs in terms of TPP amount. The experiments on cells 
without nanoparticles were also performed under the same experimental 
conditions as the control for direct comparison.  
(a) (b) (c)
 
Figure 4.7  Transmission (a) and two-photon excitation fluorescence (b) images 
of HepG2 cancer cells treated with CO-T-P nanoparticles. The merged images are 
shown in (c). 
     
4.3.7 Two-photon induced cytotoxicity   
Figure 4.8 shows the light dose-dependent cell viability of HepG2 cancer cells 
treated with the nanoparticles after two-photon photodynamic treatment. It was 
found that, under laser irradiation of different light doses, the viability of the cells 
without nanoparticles was nearly 100%, indicating that the cells were not directly 
killed by the laser irradiation. The viability of the cells treated with the CO-T NPs 
only showed minor decrease when the light dose was raised up to 630 J·cm-2. In 
contrast, the cell viability of those cells treated with CO-T-P NPs dramatically 
decreased when the light dose was raised above 270 J·cm-2. The cell viability 
decreased to ~58% when the light dose was raised to 630 J·cm-2. Consistent with 
the ABDA photo-oxidation experiments, the use of conjugated polymers 
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significantly enhanced singlet oxygen generation efficiency under two-photon 
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Figure 4.8  Light dose dependent cell viability of HepG2 cancer cells treated with 
CO-T-P NPs and CO-T after two-photon photodynamic therapy treatment (Ex: 
800 nm). CO-T-P NPs: 1.4 μM; CO-T NPs: same amount of TPP with CO-T-P 
NPs. Experiments on cells without any nanoparticles were performed under the 
same irradiation conditions as the control. 
 
 This is the first demonstration of the two-photon photodynamic therapy activity 
on living cancer cells using photosensitizer-doped conjugated polymer 
nanoparticles as novel photosensitizing agents. The high versatility of conjugated 
polymers nanoparticles allows further improvement of the two-photon properties 
of photosensitizers. Even higher photodynamic therapy efficiency of 
photosensitizer doped conjugated polymer nanoparticles could be achieved by 
selecting conjugated polymers with even larger TPA cross sections and optimizing 
energy transfer efficiency between the polymers and photosensitizers. In addition, 
cellular-uptaking efficiency, biocompatibility and cancer cell targeting capability 
could be further optimized by introducing various functional groups onto the 
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nanoparticles surface. The strong two-photon emission of the conjugated polymers 
allows two-photon imaging of the cells and mapping the distribution of the 
photosensitizing drug molecules at the same time. Considering the unique 
advantage of two-photon imaging, such as in-vivo imaging with deep penetration 
depth, these novel photosensitizing agents allow simultaneous in-vivo monitoring 
during the two-photon photodynamic treatment. 
 
4.4  Conclusion 
We have demonstrated the use of photosensitizer-doped conjugated polymer 
nanoparticles for two-photon photodynamic therapy in living cells. The 
conjugated polymer PFEMO was used as the hosting material and energy donor to 
enhance two-photon excitation properties of the acceptor molecule, TPP. The 
large TPA cross section of conjugated polymers and efficient energy transfer from 
PFEMO to TPP help to enhance singlet oxygen generation efficiency under two-
photon excitation. The incorporation of polyoxyethylene short chains onto the 
nanoparticles’ surface ensures good stability for cellular applications. These 
nanoparticles have low cytotoxicity in dark and can be easily up-taken and 
internalized by HepG2 cancer cells. Furthermore, the enhanced two-photon 
photodynamic activity of the nanoparticles in living cancer cells has been 
demonstrated. These composite nanoparticles display features that are required for 
ideal photosensitizers: minimized cytotoxicity in dark and efficient two-photon 
photodynamic activity under the laser radiations. In addition, these nano-
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Water soluble conjugated polymers for simultaneous two-
photon cell imaging and two-photon photodynamic therapy 
 
 
5.1  Introduction 
A long-standing dream in the field of cancer therapy is to treat subcutaneous 
tumors noninvasively while at the same time eliminating the adverse physical 
discomfort associated with traditional chemotherapy and debilitating effect of 
actinic radiation treatments.1 Two-photon photodynamic therapy (PDT) is a 
promising noninvasive treatment of cancers and other diseases.2 Two-photon PDT 
is advantageous over the traditional one-photon counterpart in a few aspects. First, 
wavelength of the light for two-photon excitation falls into biological tissue 
transparency window (700-1000 nm), which can penetrate deeper into diseased 
tissues. Secondly, it allows working with a smaller, more confined treatment area. 
Most importantly, it renders selective activity in z-direction, which allows 3-
dimensional selectivity and thus significantly reduces side effects. The key 
prerequisite for two-photon PDT is photosensitizers that can efficiently generate 
singlet oxygen under two-photon excitation.3 However, most photosensitizers in 
clinical use have been optimized for the conventional one-photon PDT and have 
very small two-photon absorption (TPA) cross sections. Their efficiencies for 
two-photon PDT are generally low.4 To make two-photon PDT more widely 
applicable, lots of efforts have been made to synthesize new photosensitizers with 
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large TPA cross sections,5 or improve two-photon properties of traditional 
photosensitizers via energy transfer from materials with large TPA cross sections.6  
Imaging is crucial for diagnosing diseases, guiding and monitoring the 
treatment as well as following up to assess the success of the therapy treatment.7 
Imaging guided therapy is an excellent method for both localizing cancer targets 
during treatment and monitoring the treatment outcome invasively. Integration of 
fluorescence imaging with PDT has been successfully used in preclinical studies.8 
However, to use the conventional photosensitizers as both therapeutic and 
imaging agents, excitation in the UV-Visible range is generally used to generate 
fluorescence emission. This approach suffers from limited tissue penetration depth 
and strong auto-fluorescence background of biological tissues. Two-photon 
imaging has been widely recognized as a noninvasive diagnostic technique.9 The 
combination of two-photon imaging with two-photon PDT has many unique 
advantages.4,7 It is of great interest to develop effective two-photon 
photosensitizers for simultaneous two-photon imaging and photodynamic 
therapy.5a,10 
Water soluble conjugated polymers have found a lot of biological applications 
due to their large extinction coefficients, high fluorescence quantum yield and 
fluorescence amplification of small molecules through energy transfer.11 Water 
soluble conjugated polymers have also been found to display large TPA cross 
section and have been utilized as two-photon light harvesting materials to enhance 
two-photon emission of photosensitizers by energy transfer processes.12, 13 
Conjugated polymer nanoparticles contain tens of polymer chains with large TPA 
across section per particle(14a) and have been demonstrated to act as long-term 
intracellular probe for two-photon imaging due to their low cytotoxicity compared 
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with quantum dots. 14b,c So far, the TPA cross sections of the conjugated polymers 
are still relatively low, ranging from tens to ~250 GM per repeat unit at 800 nm, 
which have large room to be further improved. Although water soluble conjugated 
polymers have been reported to generate singlet oxygen under one-photon 
excitation,15, 16 there is no report on direct singlet oxygen generation by water 
soluble conjugated polymers under two-photon excitation. We recently reported 
that polyfluorene-vinylene type conjugated polymer have larger TPA cross section 
compared to polyfluorene-ethylene type.12c Thus, it would be of great interest to 
investigate two-photon induced singlet oxygen generation efficiency of water 
soluble conjugated polymers and their applications as two-photon excitation 
photosensitizers for potential applications in simultaneous two-photon PDT and 
two-photon imaging, which allows imaging guided therapy.  
In this contribution, we synthesized a series of polyfluorene-vylevynylene-
phenylene type water soluble conjugated polymers by introducing different 
substitution groups into the backbone. Electron donating methoxy group or 
electron withdrawing cyano group was introduced into the phenyl ring of 
conjugated polymer backbone for poly(9,9-bis(6’’-(N,N,N-trimethyl-ammonium) 
fluorene-2,7-ylenevinylene-co-alt-1,4-(2,5-dimethoxylphenylene)) (PFVMO) and 
poly(9,9-bis(6’’-(N,N,N-trimethylammonium)hexyl)fluorene- 2,7-ylenevinylene-
co-alt-1,4-(2,5-dicyanophenylene)) (PFVCN), respectively. The one- and two-
photon optical properties of these water soluble conjugated polymers have been 
investigated. Among three polymers, PFVCN was found to display high 
fluorescence quantum yield and much larger TPA action cross section than 
PFVMO and the un-substituted PFV. Singlet oxygen generation by these 
polymers under two-photon excitation has also been evaluated. The application of 
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PFVCN as highly bright two-photon excitation cell imaging agent with efficient 
two-photon induced photodynamic therapy effect on cancer cells have been 
successfully demonstrated. 
 
5.2  Experimental Section 
Materials: Solvents and chemicals were purchased from Sigma-Aldrich and used 
as received without further purification unless otherwise noted. Dulbecco's 
modified eagle medium (DMEM), fetal bovine serum, streptomycin, and 
penicillin were purchased from Invitrogen. THF was dried and distilled under 
sodium. 2,7-Diformyl-9,9-di(6’-bromohexy) fluorene (1)12c, 1,4-bis(diethyl 
phosphinatyl methyl)benzene (2)17a, 1,4-bis(diethyl phosphinatylmethyl)-2,5-
dimethoxybenzene (3)25a, 1,4-bis(diethylphosphinatyl methyl)-2,5-
dicyanobenzene (4)25b, and 1,3-cyclohexadiene 1,4-diethanoate (CHDDE)24 were 
prepared according to the reported procedures.   
Synthesis of the neutral conjugated polymers. A solution of phosphonate (2, 3, 
or 4) (0.5 mmol) and monomer 1 (0.5 mmol) in dry THF (20 mL) was stirred at 
room temperature. After potassium tert-butoxide (2 mmol) was slowly added, the 
solution was stirred for 4h at room temperature before being quenched with dilute 
aqueous HCl (20 mL). The solution was then poured into methanol (250 mL) 
under stirring. The precipitate was collected by filtration. The crude polymer was 
dissolved in THF, precipitated in methanol three times, and then dried under 
vacuum to give solid product. 
Poly(9,9-bis(6’’-(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-
phenylene) (PFV-Br). Pure PFV-Br was obtained in 32% yield as a yellow solid. 
1H NMR (300MHz, CDCl3, δ ): 7.69 (br, 2H), 7.58-7.49 (br, 8H), 6.98 (s, 4H), 
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3.28 (br, 4H), 2.10 (br, 4H), 1.65-1.58 (br, 4H), 1.18-1.09 (br, 8H), 0.68-0.53 (br, 
4H); GPC: Mn=17100, Mw=30965, PDI=1.81. 
Poly(9,9-bis(6’’-(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-(2,5-
dimethoxyl phenylene)) (PFVMO-Br). Pure PFVMO-Br was obtained in 41% 
yield as a yellow solid. 1H NMR (300MHz, CDCl3, δ): 7.82-7.37 (m, 14H), 3.88 
(br, 6H), 3.28 (br, 4H), 2.10 (br, 4H), 1.65-1.58 (br, 4H), 1.18-1.09 (br, 8H), 0.68-
0.53 (br, 4H); GPC: Mn=19200, Mw=40714, PDI=2,12. 
Poly(9,9-bis(6’’-(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-(2,5-
dicyanophenylene)) (PFVCN-Br). Pure PFVCN-Br was obtained in 30% yield as 
an orange solid. 1H NMR (300MHz, CDCl3, δ): 7.89-7.48 (m, 14H), 3.25 (br, 4H), 
2.08 (br, 4H), 1.55 (br, 4H), 1.17-1.11 (br, 8H), 0.61 (br, 4H); GPC: Mn=10100, 
Mw=20010, PDI=1.98. 
Preparation of ionic polymers: PFV-Br, PFVMO-Br and PFVCN-Br were 
dissolved in chloroform (20 mL). Trimethylamine (5 mL, 30%) in ethanol was 
then added. The mixture was stirred for 48 h at room temperature. The solid 
products PFV, PFVMO and PFVCN were obtained after evaporation of the 
solvent at vacuum. (a) 1H NMR (300MHz, DMSO-d6, δ) for PFV:  8.09-7.27 (m, 
14H), 3,18 (br, 18H), 2.95 (br, 4H), 1.45 (br, 4H), 1.26-1.05 (br, 8H), 0.54 (br, 
4H). (b) 1H NMR (300MHz, DMSO-d6, δ) for PFVMO: 8.01-7.37 (m, 14H), 3.83 
(s, 6H), 3,17 (br, 18H), 2.95 (br, 4H), 1.47 (br, 4H), 1.27-1.05 (br, 8H), 0.55 (br, 
4H). (c) 1H NMR (300MHz, DMSO-d6, δ) for PFVCN: 7.95-7.42 (m, 14H), 3,18 
(br, 18H), 2.97 (br, 4H), 1.48 (br, 4H), 1.23-1.08 (br, 8H), 0.55 (br, 4H). 
Characterizations: 1H NMR spectra were recorded on 300 MHz AC Bruker 
spectrometers. Mass spectra were measured by using an AEI M850-MS 
spectrometer. GPC analysis was carried out on a Waters Styragel system using 
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polystyrene as the calibration standard and THF as eluent. UV-Vis absorption and 
fluorescence spectra were measured by using a Shimadzu UV-Vis 
spectrophotometer and a Jobin-Yvon Fluoromax-4 spectro-fluorometer, 
respectively. Size distribution was measured by dynamic light scattering (DLS) 
(Zetasizer Nano ZS, Malvern). The fluorescence quantum yield of the polymers 
were measured by using fluorescein in aqueous solution (pH = 11) as the standard. 
Two-photon excitation fluorescence (TPEF) measurements: TPEF 
measurements were performed by using a Avesta TiF-100M femtosecond (fs) 
Ti:sapphire oscillator as the excitation source. The output laser pulses have pulse 
duration of ~80 fs and a repetition rate of 84.5 MHz in the wavelength range from 
750 to 850 nm. The laser beam was focused onto the sample that was contained in 
a cuvette with path length of 1 cm. The emission was collected at an angle of 90º 
to the incoming excitation beam by a pair of lenses and an optical fiber that was 
connected to a monochromater (Acton, Spectra Pro 2300i) coupled CCD 
(Princeton Instruments, Pixis 100B) system. A short pass filter with cutoff 
wavelength at 750 nm was placed before the spectrometer to minimize the 
scattering from the pump beam. Fluorescein in water (pH=11), which have been 
well characterized in the literature,26 was used as reference (r). The two-photon 
absorption cross section of a sample can be calculated at each wavelength 
according to 
                                                         (1), 
where S is the two-photon fluorescence signal, φ is the fluorescence quantum 
yield, and C is the concentration of the chromophore6a. The concentration of the 
solution was in the range of 1 μM to 2 μM. The uncertainty in the measurement of 
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Detection of singlet oxygen: One-photon excitation singlet oxygen generation 
was directly monitored by the characteristic emission of singlet oxygen at ~1270 
nm in CH3OD solution. The singlet oxygen emission was measured by using a 
Fluorolog-3 iHR spectrofluorometer (Jobin-Yvon) equipped with a near-infrared 
sensitive photomultiplier (Hamamatsu model: R5509-72) operated at -80 ºC. An 
850 nm long-pass filter was placed before the detector. TMPyP4 in D2O was used 
as the reference (r).3d Singlet oxygen generation yield (ФΔ) of the sample under 
one-photon excitation can be calculated according to 
                                            (2), 
where I is the emission intensity of singlet oxygen at ~1270 nm, A is the 
absorbance of the solution. τ is the lifetime of singlet oxygen phosphorescence in 
selected solvent.27 
Two-photon excitation singlet oxygen generation was monitored by chemical 
oxidation of CHDDE in the aqueous solution. The sample solution was prepared 
by combing 1.0 mL of the polymer aqueous solution with CHDDE. The laser 
beam was focused onto a cuvette (1 cm path length) containing the sample 
solution. The decrease in the CHDDE absorbance was monitored under irradiation 
with fs laser pulses at 810 nm.  
Cell culture: The Hela cancer cells were cultured in growth media (DMEM 
supplemented with fetal bovine serum (10%), streptomycin (100.0 mg/L) and 
penicillin (100 IU/mL)). Cells were maintained in a humidified atmosphere of 5% 
CO2 at 37 °C. 
Proliferation assay: Cell viability was determined by using the XTT colorimetric 
cell proliferation kit (Roche) following manufacturer’s guidelines. Briefly, cells 
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24 h in the absence of compounds) in 96-well plates. The medium was aspirated 
and then treated with media (0.1 mL) containing different amounts of polymers or 
TMPyP4. After incubation for 24 h, proliferation was assayed by using the XTT 
colorimetric cell proliferation kit (Roche). A total of three replicas were 
performed.  
Two-photon cell imaging: Hela cancer cells were seeded on glass-bottom dishes 
(Mattek) and grown until 70~80% confluence. The polymers or TMPyP4 (0.5 μM) 
were added into the media and incubated for 3 h. After washing with the PBS 
buffer solution, DMEM media were added. The cancer cells were treated with 
PFV, PFVMO, PFVCN and TMPyP4 for 3 h before the images were taken by 
using a Leica TCS SP5X confocal microscope system equipped with a water 
immersion objective (Leica HCX PL APO 63x/1.20 W CORR CS). A Ti-Sapphire 
oscillator at 810 nm was used as the two-photon excitation source. Images were 
processed by using Leica Application Suite Advanced Fluorescence (LAS AF) 
software.  
Two-photon photodynamic therapy activity on cancer cells: Hela cancer cells 
were grown to 20-30% confluence in a 96-well plate. The medium was aspirated, 
washed with PBS, and then treated with media (0.1 mL) containing PFVCN or 
TMPyP4. After incubation overnight in dark, cells were washed using PBS and re-
cultured in a serum-containing DMEM medium. Each well was exposed to 1 kHz 
femtosecond laser irradiation at 810 nm with power density of ~3.0 W·cm-2. Cells 
after PDT treatments were further incubated for 24 h for apoptosis followed by the 
XTT assay of the cell proliferation. Cell experiments without nanoparticles under 
the same experimental conditions were performed for direct comparison. 
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5.3  Results and discussions 
5.3.1 Synthesis of the polymers 
The synthetic procedures of three conjugated polymers are shown in Scheme 5.1. 
Poly(9,9-bis(6’’-(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-phenylene) 
(PFV-Br), Poly(9,9-bis(6’’-(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-
(2,5-dimethoxylphenylene)) (PFVMO-Br) and Poly(9,9-bis(6’’-
(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-(2,5-dicyanophenylene)) 
(PFVCN-Br) were synthesized by using a previously reported method via the 
Witting-Horner condensation reaction between dialdehyde and 1,4-
bis(diethylphosphinatylmethyl) phenylene in dry THF by slowly adding 1 equiv of 
t-BuOK.12c Water soluble cationic conjugated polymers PFV, PFVMO and 
PFVCN were obtained by quaternization of the neutral polymers PFV-Br, 
PFVMO-Br and PFVCN-Br in excess of trimethylammonium in 
methanol/chloroform at room temperature for 48 h. The molecular weights of the 
neutral polymers were determined by gel permeation chromatography (GPC) 
using THF as the eluent. The number-averaged molecular weights (Mn) for PFV-
Br, PFVMO-Br, and PFVCN-Br were determined to be 17100 with PDI (Mw/Mn) 
=1.81, 19200 with PDI=2.12, and 10100 with PDI = 1.98, respectively. The 
numbers of repeat unit for PFV-Br, PFVMO-Br, and PFVCN-Br are 28, 29, and 
15, respectively. The polydispersity properties of the polymers are summarized in 
Table 1. 




Scheme 5.1  Synthesis procedures of three conjugated polymers. 
 
Table 5.1  Polydispersity properties of the conjugated polymers 
Polymers Mn (g· mol-1) PDI Number of repeat unit 
PFV-Br 17100 1.81 28 
PFVMO-Br 19200 2.12 29 
PFVCN-Br 10100 1.98 15 
 
5.3.2  One-photon optical properties 
The one-photon optical properties of three water soluble conjugated polymers in 
aqueous solution are shown in Figure 5.1. The absorption maxima of PFV, 
PFVMO and PFVCN are located 435, 451 nm 469 nm, while the corresponding 
emission maxima are located at 483, 510 nm and 556 nm, respectively. The 
absorption and emission spectra of PFVMO and PFVCN are red-shifted relative to 
those of PFV. The red-shift of absorption and emission maxima from PFV to 
PFVMO and PFVCN can be ascribed to introduction of electron donating 
methoxy group and electron withdrawing cyano group in the conjugated backbone 
that extend the conjugation length.17 




Figure 5.1  Normalized absorption (solid lines) and fluorescence spectra (dash 
lines) of PFV, PFVMO, and PFVCN in water. 
 
The quantum yields (QYs) of PFV, PFVMO and PFVCN were measured to 
1.8%, 1.5%, and 20% in water, and 33%, 28% and 42% in methanol, respectively. 
Cationic conjugated polymers generally display low emission efficiency in water 
due to formation of aggregates driven by the highly hydrophobic conjugated 
backbone and aggregation-induced quenching of intrachain singlet excition.18 It is 
interesting to note that QY of PFVCN is still relatively high (20%). A few water 
soluble conjugated polymers were previously reported to display reasonably high 
QY in water, which was ascribed to the formation of excimer-like state via 
interchain interactions.18b,19 Substitution of electron withdrawing cyano groups in 
an aromatic hydrocarbons can promote formation of DA-like exciplex through 
interactions with other aromatic hydrocarbons (acting as electron donors).20 For 
PFVCN in water, aggregation promotes the formation of DA excimer-like state 
via the interchain interaction between the bicyano substituted benzene units with 
aromatic fluorene units (electron donors), resulting in a relatively high QY. In 
PFV and PFVMO, non-fluorescent (or very weakly fluorescent) aggregates 
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formed, which act as an energy trap and lead to rapid quenching of the intrachain 
exciton and very low QY.18b,19 
All the polymers showed monoexponential decay dynamics in methanol (good 
solvent), indicating non-aggregates in methanol (Figure 5.2). The decay times are 
638 ps, 766 ps, and 950 ps for PFV, PFVMO and PFVCN in methanol, 
respectively. In water, the polymers were found to form aggregation driven by the 
highly hydrophobic conjugated backbone and the charged side chains. For PFV 
and PFVMO, the overall fluorescence decays much faster in water than in MeOH. 
It is consistent with the formation of the nonfluorescent or very weakly 
fluorescent aggregates which act as an energy trap, leading to rapid quenching of 
the intrachain exciton.18c,d By contrast, for PFVCN in water, the overall 
fluorescence decays slower than that in MeOH. The decay consists of two 
components with a lifetime of 817 ps (22%) and a second lifetime of 2066 ps 
(78%). These results suggest the formation of an “excimer-like” state, which has a 
longer radiative decay time compared to the intrachain singlet exciton.19 
 
Figure 5.2  Fluorescence decay data of PFV (a), PFVMO (b), and PFVCN (c) in 
methanol and water at wavelengths corresponding to the fluorescence maximum.  
 
The formation of excimer in PFVCN has also been supported by concentration 
dependent emission data (Figure 5.3a). As the conjugated polymers form 
aggregates in water even in a very low concentration, the experiment was thus 
 (a) (b) (c)
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carried out in PFVCN solution in H2O/MeOH (90/10). At low concentrations, the 
emission maximum of PFVCN is located at ~508 nm. As the concentration 
increases, a new broad and red-shifted emission band with maximum at 555 nm 
appears. The red shift spectra can be ascribed to the formation of excimer-like 
aggregates.20 The fluorescence lifetime decay of PFVCN in concentrated solution 
(2 µM) is strongly wavelength dependent (Figure 5.3b). The emission decay at 
505 nm can be well fit with double exponential decays with τ1 = 817 ps (71%) and 
τ2 = 2161 ps (29 %), while the emission decay at 605 nm can be fit with τ1 = 817 
ps (30 %) and τ2 = 2234 ps (70 %). The longer lifetime species can be ascribed to 
the formation of fluorescent excimer-like aggregates, consistent with the previous 
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Figure 5.3  (a) Concentration dependent fluorescence spectra of PFVCN in 
H2O/MeOH (90/10); (b) Fluorescence lifetime decay curves of PFVCN in 0.15 
µM and 2 µM.  
 
The high fluorescence QY of PFVCN is advantageous for its applications in 
bio-imaging. Dynamic light scattering (DLS) measurement (Figure 5.4) shows 
that the average particle size of three conjugated polymer aggregates are 32, 27, 
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and 122 nm, for PFV, PFVMO and PFVCN, respectively, which are in the range 
for efficient cell uptake.21 
 
Figure 5.4  Dynamic light scattering (DLS) data of the water soluble conjugated 
polymers in water. 
 
 
5.3.3  Two-photon optical properties 
Two-photon excitation properties of the cationic polymers PFV, PFVMO, and 
PFVCN were measured by using femtosecond laser pulses from 750 to 850 nm 
(Figure 5.5a). The two-photon excitation nature was confirmed by excitation 
intensity dependent fluorescence intensity of the polymers under excitation at 810 
nm. The log-log plots (Figure 5.5b) give slopes of 2.0 ± 0.1 for all three polymers. 
The quadratic dependence of their emission intensities on excitation power 
confirms that the observed emission indeed arises from two-photon excitation. 
The maximum TPA cross section was located at ~760 nm for PFV and PFVMO, 
and 810 nm for PFVCN. This is important for practical applications because the 
central wavelength of the most readily available femtosecond laser source is 
located at ~800 nm. The maximum TPA cross section value per repeat unit 
reached 370 GM for PFV, 390 GM for PFVMO, and 891 GM for PFVCN, 
respectively. The TPA cross section per repeat unit has been enhanced by ~2.4 
folds by introducing strong electron withdrawing cyano group into phenyl ring of 
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the backbone. This result is consistent with the previous studies on cyano-
substituted conjugated small molecules,17 which is ascribed to increased 
conjugation length due to electron withdrawing effects of cayno group and less 
degree of distortion from planarity. 
(a) (b)
Figure 5.5  (a) Two-photon excitation spectra of PFV, PFVMO, and PFVCN in 
water. The TPA cross section values were calculated base on per repeat unit of the 
polymers (GM per RU). The inset shows their photographs under fs laser 
excitation at 810 nm. (b) Excitation power dependence of fluorescence intensity 
under excitation at 810 nm. 
 
 



















PFV 435 2.43 × 104 483 1.8 253 4.55 7084 128 
PFVMO 451 1.31 × 104 510 1.5 265 3.97 7685 115 
PFVCN 469 1.48 × 104 556 20 891 179 13365 2673 
TMPyP4 421 24.0 × 104 657 0.3 10 0.03 10 0.03 
(a) Measured in water solutions, fluorescein in NaOH water solution (PH = 11) 
was used as a standard for quantum yield measurements. (b) TPA cross section 
per repeat unit at 810 nm. (c) TPA action cross section per repeat unit at 810 nm. 
(d) TPA cross section per molecule. (e) TPA action cross section per molecule. 
 
TPA action cross section (φδ) is usually used to evaluate the brightness of two-
photon fluorophores, where δ is the TPA cross section and φ is the fluorescence 
quantum yield.22 So far a few reported water soluble chromophores showed TPA 
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action cross section values ranging from 10 to 700 GM in water in the non-
aggregated form.23 The TPA action cross section values of the prepared PFV, 
PFVMO, and FPVCN were calculated to be 4.55 GM, 3.97 GM, and 179 GM per 
repeat unit. In practical applications, TPA action cross value is generally 
calculated base on a molecule or a nanoparticle containing several 
molecules.11b,14b The TPA action cross values based on a molecule were calculated 
to be 128 GM, 115 GM, and 2673 GM per molecule for PFV, PFVMO, and 
PFVCN (Table 5.2). The two-photon excitation fluorescence of PFVCN can be 
even directly visualized with naked eyes (Figure 5.5a inset) due to its high TPA 
action cross section. These water soluble conjugated polymers are expected to 
display high brightness in two-photon imaging applications. 
 
5.3.3  Dark cytotoxicity 
Good biocompatibility and low dark cyto-toxicity are essential for any 
chromophore in biological applications such as bio-imaging and phototherapy. 
The cytotoxicity of three water soluble conjugated polymers in dark was evaluated 
by monitoring the metabolic viability of Hela cells. Figure 5.6 shows the cell 
viability after incubation with PFV, PFVMO, PFVCN, and TMPyP4 at different 
concentrations for 24 h in dark. The metabolic viability of the cells remained 
nearly 100% when the concentrations of polymers reached up to 40 μM. The low 
dark cytotoxicity of the polymers ensures their applications in real practice. 




Figure 5.6  Metabolic viability of Hela cells after incubation with PFV, PFVMO, 
PFVCN and TMPyP4 of different concentrations (in repeat unit for polymers) for 
24 h. 
 
5.3.4  Two-photon excitation cell imaging 
The large TPA action cross sections of these conjugated polymers, in particular 
PFVCN, make them attractive candidates for two-photon imaging agents. Two-
photon excitation cell imaging using PFV, PFVMO, PFVCN, and TMPyP4 were 
demonstrated by using HeLa cancer cells under excitation at 810 nm using a two-
photon laser scanning confocal microscopy (Figure 5.7). Intense fluorescence 
signals were observed from the cells treated with PFVCN, while relatively weak 
fluorescence signals were observed from cells treated with PFV and PFVMO 
under identical experimental conditions, which is consistent with their relative 
TPA actions cross section values. No fluorescence signal was observed from cells 
treated with TMPyP4 as expected, due to its low quantum yield and small TPA 
cross section. Overlaid pictures of the two-photon excitation fluorescence images 
and bright field images show that these polymers were successfully taken up and 
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internalized into the cells after incubation for 3 hours. These results indicate that 
these water soluble polymers, in particular PFVCN, can act as promising agents 
for two-photon cell imaging with high brightness. 
 
Figure 5.7  Overlaid images of two-photon excitation fluorescence and bright 
field images of Hela cancer cells treated with PFV (a), PFVMO (b), PFVCN (c), 
and TMPyP4 (d) for 3 h. Scale bar: 10 μm.  
 
5.3.5  Singlet oxygen generation 
Singlet oxygen is responsible for killing cancer cells in PDT. High singlet oxygen 
generation efficiency is required for the application of photosensitizers in PDT. 
Some water soluble conjugated polymers are known to generate singlet oxygen 
and could also be used as photosensitizers.15c, 15d Singlet oxygen generation 
efficiencies of PFV, PFVMO and PFVCN were examined by monitoring the 
characteristic emission peak of singlet oxygen at ~1270 nm in CD3OD solution. 
Under excitation at their corresponding absorption maxima, three polymers all 
displayed the characteristic singlet oxygen emission band at ~1270 nm (Figure 
5.8a), which disappeared in oxygen deficient solution by bubbling with N2 gas for 
about 15 min (Figure 5.8b). This result confirms that the observed emission peak 
indeed originates from singlet oxygen generated from the interaction between the 
polymers and molecular oxygen. Using TMPyP4 in D2O as standard, the singlet 
oxygen generation yields were calculated to be 5.6 %, 4.3 %, and 6.9 % for PFV, 
PFVMO, and PFVCN, respectively. 




Figure 5.8  (a) Phosphorescence spectra of singlet oxygen generated by PFV, 
PFVMO, and PFVCN in CD3OD under one-photon excitation. TMPyP4 in D2O 
was used as the standard. (b) Phosphorescence spectra of singlet oxygen generated 
by PFVCN after bubbling with O2 for 15min or bubbling with N2 for 15 min in 
CD3OD under one-photon excitation. The emission peak at ~1270 nm disappeared 
in oxygen deficient solution by bubbling with N2 for 15 min. 
 
 
Two-photon induced singlet oxygen generation of the polymers in water was 
evaluated by a chemical method using 1,3-cylcohexadiene-1,4-diethanoate 
(CHDDE) as a probe. In this method, CHDDE reacts with singlet oxygen to form 
peroxide and hydroperoxide, leading a decrease in its absorption band at 270 
nm.24 The UV absorption at 270 nm was monitored during the course of 
irradiation by femtosecond laser pulses at 810 nm in the presence of polymers. 
The control experiments were done in the presence of TMPyP4 under the same 
experimental conditions. As shown in Figure 5.9, the CHDDE photo-oxidation 
rate in the presence of PFVCN is significantly faster than that in the presence of 
PFV, PFVMO, and TMPyP4. The trend is consistent with their two-photon 
induced singlet oxygen generation capability, which could be characterized by 
δФΔ, the product of TPA cross section and singlet oxygen generation efficiency. 
As shown in Table 5.3, δФΔ of PFVCN is 61 GM per repeat unit, ~8 times higher 
than that of TMPyP4 (7.4). This result indicates that PFVCN can generate singlet 
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oxygen under two-photon excitation with high efficiency and thus can be utilized 
as photosensitizers for two-photon PDT. 
 
Figure 5.9  Comparison of time dependent CHDDE degradation in presence of 
PFV, PFVMO, PFVCN and TMPyP4 under two-photon excitation at 810 nm. 
 
 
Table 5.3  Singlet oxygen generation efficiency of the conjugated polymers and 
TMPyP4 
Compound δ (GM) (a) ФΔ (%) (b) δФΔ 
PFV 253 5.6 14 
PFVMO 265 4.3 11 
PFVCN 891 6.9 61 
TMPyP4 10 74 (c) 7.4 
(a) TPA absorption cross section per repeat unit at 810 nm. (b) Singlet oxygen 
generation yield ФΔ was calculated based on the singlet oxygen luminescence 
intensity at ~1270 nm, using TMPyP4 as the standard. (c) Value taken from Ref.3d 
 
5.5.6  Two-photon induced cytotoxicity 
Since PFVCN display much larger δФΔ compared to PFV, PFVMO and TMPyP4, 
we further explored its potential application as a two-photon PDT photosensitizing 
agent. The viability of Hela cancer cells incubated with PFVCN or without 
PFVCN were examined after exposure to femtosecond laser irradiation at 810 nm 
with energy density of ~3.0 W·cm-2. The laser beam was unfocused with a beam 
size of ~0.3 cm2. The final concentration of PFVCN was 20 μM (in repeat unit). 
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For direct comparison, the experiments on cells treated with TMPyP4 of the same 
concentration were also performed under the same experimental conditions. 
Figure 5.10 shows irradiation time dependent cell viability of Hela cancer cells 
after two-photon photodynamic treatment. The viability of the cells without 
PFVCN was found to remain nearly 100% under laser irradiation for 10 min, 
indicating that the cells were not directly killed by the laser irradiation. In contrast, 
the viability of the cells treated with PFVCN showed dramatically decrease with 
the increasing laser irradiation time. The cell viability decreased to ~46% when 
the irradiation time reached 10 min. In comparison, the viability of the cells 
treated with TMPyP4 showed no obvious change under the same condition, 
consistent with the much smaller TPA cross section of TMPyP4. These results 
indicate that PFVCN can act as efficient photosensitizers for two-photon 
photodynamic treatment on cancer cells, owing to its large TPA cross section and 
capability of singlet oxygen generation (δФΔ). 
 
Figure 5.10  Laser irradiation time dependent cell viability of Hela cancer cells 
treated with PFVCN and TMPyP4 after two-photon PDT treatment (irradiation by 
fs laser pulses at 810 nm). Experiments on cells without any photosensitizers were 
performed under the same irradiation condition as the control. 
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5.4  Conclusions 
In summary, we have developed water soluble conjugated polymers with large 
two-photon absorption cross sections for simultaneous two-photon cell imaging 
and two-photon photodynamic therapy. Three different water soluble conjugated 
polymers, poly(fluorene-2,7-ylenevinylene-co-phenylene) with different 
substitution groups on the backbone, have been synthesized.  By introducing 
strong electron withdrawing cyano group into phenyl ring of the backbone, 
PFVCN displayed 2.4 time higher maximum two-photon absorption cross section 
per repeat unit and significantly higher fluorescence quantum yield (~20%) in 
water than the unsubstituted PFV. The TPA action cross section of PFVCN is 39 
times higher than that of PFV at 810 nm. The large two-photon action cross 
section of PFVCN makes it a promising material for two-photon cell imaging. 
Moreover, PFVCN displayed high two-photon induced singlet oxygen generation 
activity due to its large TPA cross section and reasonable singlet oxygen 
generation yield. The two-photon photodynamic therapy effect of PFVCN on 
cancer cells was found to be much higher than porphyrin type photosensitizer, 
TMPyP4. These studies suggest that water soluble conjugated polymers can be 
developed as promising novel photosensitizing agents with dual capability of two-
photon imaging and two-photon photodynamic therapy, which allows two-photon 
imaging guided therapy. 
 
5.5  References 
1. a) D. E. J. G. J. Dolmans, D. Fukumura, R. K. Jain, Nat. Rev. Cancer 2003, 3, 380; b) A. 
P. Castano, P. Mroz, M. R. Hamblin, Nat. Rev. Cancer 2006, 6, 535; c) C. M. Moore, D. 
Pendse, M. Emberton, Nat. Clin. Pract. Urol. 2009, 6, 18. 
2. a) K. Ogawa, Y. Kobuke, Anti-Cancer Agents Med. Chem. 2008, 8, 269; b) J. F. Lovell, T. 
W. B. Liu, J. Chen, G. Zheng, Chem. Rev. 2010, 110, 2839. 
    
113 
 
3. a) N. L. Oleinick, R. L. Morris, I. Belichenko, Photochem. Photobiol. Sci. 2002, 1, 1; b) T. 
C. Zhu, J. C. Finlay, Med. Phys. 2008, 35, 3127; c) P. K. Frederiksen, M. Jorgensen, P. R. 
Ogilby, J. Am. Chem. Soc. 2001, 123, 1215; d) P. K. Frederiksen, S. P. McIlroy, C. B. 
Nielsen, L. Nikolajsen, E. Skovsen, M. Jorgensen, K. V. Mikkelsen, P. R. Ogilby, J. Am. 
Chem. Soc. 2005, 127, 255. 
4. H. A. Collins, M. Khurana, E. H. Moriyama, A. Mariampillai, E. Dahlstedt, M. Balaz, M. 
K. Kuimova, M. Drobizhev, V. X. D. Yang, D. Phillips, A. Rebane, B. C. Wilson, H. L. 
Anderson, Nat. Photonics 2008, 2, 420. 
5. a) C. B. Nielsen, J. Arnbjerg, M. Johnsen, M. Jorgensen, P. R. Ogilby, J. Org. Chem. 
2009, 74, 9094; b) J. Arnbjerg, M. J. Paterson, C. B. Nielsen, M. Jorgensen, O. 
Christiansen, P. R. Ogilby, J. Phys. Chem. A 2007, 111, 5756; c) M. Velusamy, J. Y. Shen, 
J. T. Lin, Y. C. Lin, C. C. Hsieh, C. H. Lai, C. W. Lai, M. L. Ho, Y. C. Chen, P. T. Chou, 
J. K. Hsiao, Adv. Funct. Mater. 2009, 19, 2388; d) M. K. Kuimova, H. A. Collins, M. 
Balaz, E. Dahlstedt, J. A. Levitt, N. Sergent, K. Suhling, M. Drobizhev, N. S. Makarov, A. 
Rebane, H. L. Anderson, D. Phillips, Org. Biomol. Chem. 2009, 7, 889; e) M. Balaz, H. A. 
Collins, E. Dahlstedt, H. L. Anderson, Org. Biomol. Chem. 2009, 7, 874. 
6. a) Y. Tian, C. Y. Chen, Y. J. Cheng, A. C. Young, N. M. Tucker, A. K. Y. Jen, Adv. 
Funct. Mater. 2007, 17, 1691; b) W. R. Dichtel, J. M. Serin, C. Edder, J. M. J. Frechet, M. 
Matuszewski, L. S. Tan, T. Y. Ohulchanskyy, P. N. Prasad, J. Am. Chem. Soc. 2004, 126, 
5380; c) R. P. Brinas, T. Troxler, R. M. Hochstrasser, S. A. Vinogradov, J. Am. Chem. 
Soc. 2005, 127, 11851; d) C. Y. Chen, Y. Q. Tian, Y. J. Cheng, A. C. Young, J. W. Ka, A. 
K. Y. Jen, J. Am. Chem. Soc. 2007, 129, 7220; e) S. Kim, T. Y. Ohulchanskyy, H. E. 
Pudavar, R. K. Pandey, P. N.Prasad, J. Am. Chem. Soc. 2007, 129, 2669. 
7. J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue, T. 
Hasan, Chem. Rev. 2010, 110, 2795. 
8. a) M. Loning, H. Diddens, W. Kupker, K. Diedrich, G. Huttmann, Cancer 2004, 100, 
1650; b) P. Redondo, M. Marquina, M. Pretel, L. Aguado, M. E. Iglesias, Arch. Dermatol. 
2008, 144, 115; c) W. Zhong, J. P. Celli, I. Rizvi, Z. Mai, B. Q. Spring, S. H. Yun, T. 
Hasan, Brit. J. Cancer 2009, 101, 2015. 
9. a) W. R. Zipfel, R. M. Williams, W. W. Webb, Nat. Biotechnol. 2003, 21, 1368; b) F. 
Helmchen, W. Denk, Nat. Methods 2005, 2, 932. 
10. X. Shen, L. Li, H. Wu, S. Q. Yao, Q.-H. Xu, Nanoscale 2011, 3, 5140. 
11. a) S. W. Thomas, G. D. Joly, T. M. Swager, Chem. Rev. 2007, 107, 1339; b) C. F. Wu, C. 
Szymanski, Z. Cain, J. McNeill, J. Am. Chem. Soc. 2007, 129, 12904. c) C. L. Zhu, L. B. 
Liu, Q. Yang, F. T. Lv, S. Wang, Chem. Rev. 2012, 112, 4687. 
12. a) N. Tian, Q. H. Xu, Adv. Mater. 2007, 19, 1988; b) C. L. Wu, Q. H. Xu, Macromol. 
Rapid Commun. 2009, 30, 504; c) F. He, X. Ren, X. Shen, Q.-H. Xu, Macromolecules 
2011, 44, 5373. 
13. X. Q. Shen, F. He, J. H. Wu, G. Q. Xu, S. Q. Yao, Q. H. Xu, Langmuir 2011, 27, 1739. 
    
114 
 
14. a) C. F. Wu, C. Szymanski, Z. Cain, J. McNeill, J. Am. Chem. Soc. 2007, 129, 12904; b) 
K. S. Schanze, A. Parthasarathy, H. Y. Ahn, K. D. Belfield, ACS Appl. Mater. Inter. 2010, 
2, 2744; c) N. A. A. Rahim, W. McDaniel, K. Bardon, S. Srinivasan, V. Vickerman, P. T. 
C. So, J. H. Moon, Adv. Mater. 2009, 21, 3492.  
15. a) L. D. Lu, F. H. Rininsland, S. K. Wittenburg, K. E.; Achyuthan, D. W. McBranch, D. 
G. Whitten, Langmuir 2005, 21, 10154; b) S. Chemburu, T. S. Corbitt, L. K. Ista, E. Ji, J. 
Fulghum, G. P. Lopez, K. Ogawa, K. S. Schanze, D. G. Whitten, Langmuir 2008, 24, 
11053; c) T. S. Corbitt, L. P. Ding, E. Y. Ji, L. K. Ista, K. Ogawa, G. P. Lopez, K. S. 
Schanze, D. G. Whitten, Photochem. Photobiol. Sci. 2009, 8, 998; d) E. Ji, T. S. Corbitt, 
A. Parthasarathy, K. S. Schanzes, D. G. Whitten, ACS Appl. Mater. Inter. 2011, 3, 2820;  
16. a) H. Chong, C. Y. Nie, C. L. Zhu, Q. Yang, L. B. Liu, F. T. Lv, S. Wang, Langmuir 2012, 
28, 2091; b) X. Duan, L, Liu, X. Feng, S. Wang, Adv. Mater. 2010, 22, 1. 
17. a) S. J. K. Pond, M. Rumi, M. D. Levin, T. C. Parker, D. Beljonne, M. W. Day, J. L. 
Bredas, S. R. Marder, J. W. Perry, J. Phys. Chem. A 2002, 106, 11470; b) S. K. Lee, W. J. 
Yang, J. J. Choi, C. H. Kim, S. J. Jeon, B. R. Cho, Org. Lett. 2005, 7, 323. 
18. a) H. A. Ho, M. Leclerc, J. Am. Chem. Soc. 2004, 126, 1384; b) X. Y. Zhao, M. R. Pinto, 
L. M. Hardison, J. Mwaura, J. Muller, H. Jiang, D. Witker, V. D. Kleiman, J. R. Reynolds, 
K. S. Schanze, Macromolecules 2006, 39, 6355; c) M. Fakis, D. Anestopoulos, V. 
Giannetas, P. Persephonis, J. Mikroyannidis, J. Phys. Chem. B 2006, 110, 12926; d) T. Q. 
Nguyen, V. Doan, B. J. Schwartz, J. Chem. Phys. 1999, 110, 4068. 
19. a) C. Tan, M. R. Pinto, K. S. Schanze, Chem. Commun. 2002, 446; b) B. J. Schwartz, 
Annu. Rev. Phys. Chem. 2003, 54, 141. 
20. J. B. Birks, Rep. Prog. Phys. 1975, 38, 903. 
21. a) X. L. Feng, Y. L. Tang, X. R. Duan, L. B. Liu, S. Wang, J. Mater. Chem. 2010, 20, 
1312; b) C. Wu, B. Bull, C. Szymanski, K. Christensen, J. McNeill, ACS Nano 2008, 2, 
2415. 
22. a) Z. Fang, X. H. Zhang, Y. H. Lai, B. Liu, Chem. Commun. 2009, 920; b) Kim, S.; Zheng, 
Q.; G. S. He, D. J. Bharali, H. E. Pudavar, A. Baev, P. N. Prasad, Adv. Funct. Mater. 2006, 
16, 2317. 
23. a) H. Y. Woo, J. W. Hong, B. Liu, A. Mikhailovsky, D. Korystov, G. C. Bazan, J. Am. 
Chem. Soc. 2005, 127, 820; b) H. Y. Woo, D. Korystov, A. Mikhailovsky, T. Q. Nguyen, 
G. C. Bazan, J. Am. Chem. Soc. 2005, 127, 13794. 
24. V. Nardello, N. Azaroual, I. Cervoise, G. Vermeersch, J. M. Aubry, Tetrahedron 1996, 52, 
2031. 
25. a) J. K. Lee, R. R. Schrock, D. R. Baigent, R. H. Friend, Macromolecules 1995, 28, 1966; 
b) J. Eldo, A. Ajayaghosh, Chem. Mater. 2002, 14, 410. 
26. C. Xu, W. W. Webb, J. Opt. Soc. Am. B 1996, 13, 481. 




Chapter 6  
High efficient conjugated polymer nanophotosensitizers for 
targeted two-photon photodynamic therapy 
 
 
6.1  Introduction 
Two-photon photodynamic therapy (PDT) is a promising noninvasive treatment of 
cancers and other diseases.1 Two-photon PDT is advantageous over the traditional 
one-photon counterpart in a few aspects.2,3 First, wavelength of the light for two-
photon excitation falls into biological tissue transparency window (700-1000 nm), 
which can penetrate deeper into diseased tissues. Secondly, it allows working with 
a smaller, more confined treatment area. Most importantly, it renders selective 
activity in z-direction, which allows 3-dimensional selectivity and thus 
significantly reduces side effects. The deficiency of current photosenstizers for 
two-photon PDT application motivated researchers to explore novel high efficient 
two-photon photosensitizers to improve two-photon PDT efficiency.4,5 
Dendrimers with two-photon dyes,6,7 organically modified silica nanoparticles,8 
quantum dots9 and co-polymer micelles10 have been also utilized to develop novel 
two-photon photosensitizing agent with improved singlet oxygen generation 
ability for two-photon PDT.  
Conjugated polymers have found a lot of biological applications due to their 
large extinction coefficients, high fluorescence quantum yield.11,12 They display 
optical amplification by resonance energy transfer.13 This feature has been widely 
utilized to develop various bio-sensing and imaging schemes with enhanced 
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detection efficiency.14 Recently dye-doped conjugated polymer nanoparticles 
attracted lot of attention due to their unique intra-particle amplified energy 
transfer,15 which energy harvested by conjugated polymer segments can 
efficiencly 3-dimensionally transfer to acceptors that trapped inside the 
nanoparticle. It was also found that conjugated polymer nanoparticles can act as 
novel two-photon photosensitzers with enhanced two-photon induced singlet 
oxygen generation ability.16,17 The enhancement factor is ascribed to the 
contribution of the large difference of TPA cross section between conjugated 
polymer with the doped photosensitziers and the amplified two-photon excitation 
resonance energy transfer from conjugated polymer to photosesitizers. However, 
the two-photon induced singlet oxygen generation ability of the nanoparticles are 
still not impressive enough for potential two-photon PDT application. It is 
expected that much higher enhanced singlet oxygen generation and photodynamic 
therapy efficiency can be achieved, through selection of conjugated polymer with 
much larger TPA cross section and further optimized the energy transfer 
efficiency, Nevertheless, the TPA cross sections of the most conjugated polymers 
reported are still relatively low,18-20 rendering the amplification capability of two-
photon induced oxygen generation.  
To overcome the drawback, we made efforts on designing novel conjugated 
polymers and studying their two-photon photochemical and photophysical 
properties, and explore their two-photon biomedical applications.21 In this work, 
we prepared folate functionalized conjugated nanoparticles, using a conjugated 
polymer that with large two-photon absorption cross section, poly[9,9-bis(6’’-
(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-(2,5-dicyanophenylene)] 
(PFVCN) as light harvesting material and energy donor, and hydrophobic 
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tetraphenylporphyrin (TPP) as energy acceptor and photosensitizing molecule. 
Poly(styrene-co-maleic anhydride) (PSMA) was used as hosting matrix and 1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)-
2000] (DSPE-PEG(2000)-Folate was incorporated onto the surface of 
nanopartilces to realize the surface folate functionality. The amplified energy 
transfer from PFVCN to TPP and the two-photon excitation emission of the 
nanoparticles were studied. These nanoparticles were found to display about 3-
order amplification of two-photon properties of doped TPP, and highly efficient 
two-photon induced singlet oxyen generation ablity. The folate mediated specific 
cancer cell uptake of the nanoparticle have been studied by one-photon and two-
photon excitation fluorescence cell imaging. And the folate mediated specific two-
photon induced cytotoxicity on cancer cells have also been demonstrated to 
display significantly enhanced two-photon photodynamic activity on cancer cells. 
 
6.2  Experimental Section 
Materials: Tetraphenylporphyrin (TPP), poly(styrene-co-maleic anhydride), 
cumene terminated (PSMA) (average Mn ~1,900), 9, 10-anthracenediyl 
bis(methylene) dimalonic acid (ABDA), deuterium oxide and tetrahydrofuran 
(THF) were purchased from Sigma Aldrich. 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[folate(polyethylene glycol)-2000] (DSPE-PEG(2000)-
Folate), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] (DSPE-mPEG(2000) were purchased from 
Avanti Polar Lipids. Dulbecco's modified eagle medium (DMEM), fetal bovine 
serum, streptomycin, penicillin, phosphate buffered saline (PBS) buffer solution, 




dicyanophenylene)] (PFVCN)  was synthesized as described in the literature.21  
Preparation of TPP doped conjugated polymer nanoparticles: The conjugated 
polymer nanoparticles were prepared by using a modified re-precipitation method. 
For preparation of TPP doped conjugated polymer nanoparticles (T-P NPs), 
different amount of TPP solution in THF (0.1 mM) were mixed with 2.0 mL of 
PFVCN stock solution in THF (40 μM in repeart unit) and 8.0 μL PSMA solution 
in THF( 0.2mM) and 4 μL of DSPE-PEG(2000) solution in THF. The mixtures 
were added quickly into 8 mL deionized water under sonication, and then keep 
still for 4 hours before removal of THF by vacuum evaporation. For prepare folate 
functionalized nanoparticles (Folate-0.25%T-P NPs), the molar ratio of TPP to 
repeat unit of PFVCN was maitained to 0.25% and DSPE-PEG(2000) was replace 
with DSPE-PEG(2000)-Folate.  
Characterizations: The UV-Vis absorption and fluorescence spectra were 
measured by using a Shimadzu UV-Vis spectrophotometer and a Jobin-Yvon 
Fluoromax-4 spectro-fluorometer, respectively. The size distribution of the 
nanoparticles was measured by dynamic light scattering (DLS) (Zetasizer Nano 
ZS, Malvern).  
Two-photon excitation fluorescence (TPEF) measurements: TPEF 
measurements were performed by using a Avesta TiF-100M femtosecond (fs) 
Ti:sapphire oscillator as the excitation source. The output laser pulses have pulse 
duration of ~80 fs and a repetition rate of 84.5 MHz in the wavelength range from 
750 to 850 nm. The laser beam was focused onto the sample that was contained in 
a cuvette with path length of 1 cm. The emission was collected at an angle of 90º 
to the incoming excitation beam by a pair of lenses and an optical fiber that was 
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connected to a monochromater (Acton, Spectra Pro 2300i) coupled CCD 
(Princeton Instruments, Pixis 100B) system. A short pass filter with cutoff 
wavelength at 750 nm was placed before the spectrometer to minimize the 
scattering from the pump beam. Fluorescein in water (pH=11), which have been 
well characterized in the literature,26 was used as reference (r). The two-photon 
absorption cross section of a sample can be calculated at each wavelength 
according to 
                                                         (1), 
where S is the two-photon fluorescence signal, φ is the fluorescence quantum 
yield, and C is the concentration of the chromophore6a. The concentration of the 
solution was in the range of 1 μM to 2 μM. The uncertainty in the measurement of 
cross sections is ~15%. 
Detection of singlet oxygen: One-photon excitation singlet oxygen generation 
was directly monitored by the characteristic emission of singlet oxygen at ~1270 
nm in D2O solution. The singlet oxygen emission was measured by using a 
Fluorolog-3 iHR spectrofluorometer (Jobin-Yvon) equipped with a near-infrared 
sensitive photomultiplier (Hamamatsu model: R5509-72) operated at -80 ºC. An 
850 nm long-pass filter was placed before the detector.  
Two-photon induced singlet oxygen generation was monitored by chemical 
oxidation of ABDA in the nanoparticles water dispersions. The decrease in the 
ABDA absorbance was monitored under irradiation with femtosecond laser pulses 
at 800 nm. The sample solution was prepared by combing 1.0 mL of the 
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(0.5 mM). The laser beam was focused onto a cuvette (1 cm pathlength and 2 mm 
width) containing 0.5 mL solution. 
Cell culture: The KB cancer cells were culture in folic acid free RPMI-1640 
medium supplemented with fetal bovine serum (10%), streptomycin (100.0 mg/L) 
and penicillin (100 IU/mL). The normal NIH/3T3 fibroblast cells were cultured in 
DMEM medium supplemented with fetal bovine serum (10%), streptomycin 
(100.0 mg/L) and penicillin (100 IU/mL). Cells were maintained in a humidified 
atmosphere of 5% CO2 at 37 °C. 
Proliferation assay: Cell viability was determined by using the XTT colorimetric 
cell proliferation kit (Roche) following manufacturer’s guidelines. Briefly, cells 
were grown to 20-30% confluence (since they will reach ~90% confluence with 
24 h in the absence of compounds) in 96-well plates. The medium was aspirated 
and then treated with media (0.1 mL) containing different amounts of 0.25%T-P 
NPs or Folate-0.25%T-P NPs. After incubation for 24 h, proliferation was assayed 
by using the XTT colorimetric cell proliferation kit (Roche). A total of three 
replicas were performed.  
One-photon and two-photon excited cell Imaging: The KB cancer cells or 
normal NIH/3T3 cells were seeded on glass-bottom dishes (Mattek) and grown 
until 70~80% confluence. The nanoparticles (5 μM in repeat unit of PFVCN) were 
added into the media and incubated for 6 h. After washing with the PBS buffer 
solution, the cells were washed three times with PBS buffer solution and then 
fixed with 3.6% formal dehyde solution. The cells were further washed three 
times with PBS buffer and stained by trihydrate trihydrochloride for 15 mins, 
followed by washed three times with PBS buffer. The images were taken by using 
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a Leica TCS SP5X confocal microscope system equipped with a water immersion 
objective (Leica HCX PL APO 63x/1.20 W CORR CS), under the same 
experimental condition. The fluorescence signal from nanoparticels was collected 
from 500 nm to 600 nm under excitation at 458 nm. Two-photon fluorescence 
images were also studied by the Leica TCS SP5X confocal microscope system 
under excitation at 810 nm. A Ti-Sapphire oscillator was used as the two-photon 
excitation source. Images were processed by using Leica Application Suite 
Advanced Fluorescence (LAS AF) software.  
Two-photon photodynamic therapy activity on cancer cells: The KB cancer 
cells or normal NIH/3T3 cells were grown to 20-30% confluence in a 96-well 
plate. The medium was aspirated, washed with PBS, and then treated with 
medium (0.1 mL) containing T-P NPs, Folate-T-P NPs or bare TPP NPs. After 
incubation 12 in dark, cells were washed using PBS and re-cultured in folic acid 
free RMPI medium or normal DMEM medium. Each well was exposed to 1 kHz 
femtosecond laser irradiation at 810 nm with power density of ~3.0 W·cm-2. Cells 
after PDT treatments were further incubated for 24 h followed by the XTT assay 
of the cell proliferation. Cell experiments without nanoparticles under the same 
experimental conditions were performed for direct comparison. 
 
6.3  Results and discussions 
6.3.1  Preparation and characterization of NPs 
We have previously found that cyano group substituted conjugated polymer 
PFVCN have much large TPA cross section compared to unsubstituted conjugated 
polymer PFV. It would be interesting to ultilize PFVCN as a effective two-photon 
light harvesting materials for amplification of two-photon singlet oxygen 
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generation of photosensitizers. To this aim, hydrophobic conjugated polymer, 
PFVCN (Mw = 10100, Mw/Mn = 1.98, ~15 repeat units), was chosen as the 
energy donor to prepare nanopartiles. For the bare PFVCN nanoparticles, the 
maxium TPA cross section of  was measured to be 550 GM per repeat unit at 810 
nm.  TPP was selected as the photosensitizing acceptor because its Q absorption 
bands overlap well with the emission spectrum of PFVCN (Figure 6.1b), as well 
as the highly hydrophobic molecule can be efficiently encapsulated into the 
polymer nanoparticles.  
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Figure 6.1 (a) Normalized absorption and emission of PFVCN and TPP, (b) TPA 
cross section value of PFVCN NPs per repeat unit from 750 nm to 840 nm. 
 
PSMA have been used as hosting matrix, which can stablize the nanoparticles 
by formation of negative charged carboxyl group on the nanoparticle surface.22 
DSPE-PEG(2000) or DSPE-PEG(2000)-Folate was incorporated onto the surface 
of the nanoparticles to prepared nanoparticles without or with funtionalized 
folate.23-25 PFVCN, TPP, PSMA, and DSPE-PEG(2000)-Folate or DSPE-
PEG(2000) were mixed in THF. Rapid addition of the mixture into water under 
sonication led to collapse of polymer chains and formation of TPP entrapped 
nanoparticles. The hydrophobic DSPE segments tend to entangel with 
hydrophobic polymer nanoparticles and the hydrophilic PEG extend into the 
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aqueous phase. The suspension was maintained for about 4 hours to allow further 
conformation change of  DSPE-PEG(2000)-Folate. THF was then removed the 
vacuum rotation, and stable polymer nanoparticle formed. TEM and DLS 































Scheme 6.1  Schematic illustration of the formation of conjugated polymer 
nanoparticles for folate acceptor targeted two-photon PDT. 
 

























6.3.2  Amplified energy transfer and  two-photon optical properties 
Intra-nanoparticle amplified energy transfer from conjugated polymer to doping 
chromophore have been observed in dye doped conjugated polymer 
nanoparticles.26,27 Conjugated polymers, such as PFVCN, are constructed of 
numerous fluorescent residues that form a large conjugated system. It allows the 
excitons to move along the polymer chain until they encounter a quencher 
molecule.15 Additionally, the hydrophobic nature of the dye and the conjugated 
polymer matrix ensured close interaction between the acceptor dye and the donor 
matrix, which also enhanced efficient energy transfer. To better understand energy 
transfer from PFVCN to TPP, conjugated polymer nanoparticles: 0.125T-P NPs, 
0.25T-P NPs, 0.5T-P NPs, 1T-P NPs, 2T-P NPs and 4T-P NPs were prepared with 
different TPP doping concentration (0.125% - 4%). As shown Figure 6.3a, the 
emission of PFVCN (500-620 nm) decreased with increasing doping amount of 
TPP. A new emission band from 620-720 nm appeared which is from the emission 









































Figure 6.3 (a) Fluorescence spectra of bare PFVCN NPs and T-P NPs with 
different TPP doping concentration (0.125% - 4%), under excitation at 469 nm. (b) 
The ratio of the fluorescence intensity of bare PFVCN nanoparticles without TPP 
(F0) to nanoparticles with doped with TPP (F) as a function of TPP doping 




The energy of conjugated polymer can be efficiently quenched by TPP. The 
quenching efficiency was examined using the Stern-Volmer equation  
F0/F = 1 + Ksv[A] 
where F0 and F represent the fluorescence intensity of donor without and with the 
acceptor, respectively. The value [A] stands for the ratio of TPP to PFVCN repeat 
unit per nanoparticles, and Ksv is the Stern-Volmer quenching constant. Figure 
6.3b shows that the experimental results were in good agreement with the Stern-
Volmer relationship. The Ksv value indicates that one TPP molecule could 
potentially accept 365 repeat units  of PFVCN (24 polymer chains) in the 
nanoparticles, confirming the amplified energy transfer from PFVCN to TPP.  
To further study the contribution of conjugated polymers PFVCN as effective 
two-photon light harvesting materials to enhance the two-photon properties of 
TPP via two-photon excitation amplified energy transfer, the two-photon 
excitation emission of the doped nanoparticles were measured. As shown in 
Figure 6.4a the two-photon excitation emission of PFVCN decreased with 
increasing the doping amount of  TPP, while the two-photon excitation emission 
from TPP in the nanoparticles was significantly enhanced compared to that of bare 
TPP nanoparticles without PFVCN (Figure 6.4b). The two-photon emission 
enhancement factor for the  polymer nanoparticles doped with different amount of  
TPP was calculated. As shown in Figure 6.4c the maximum two-photon emission 
enhancement factor can be up to 1024. The high enhancement of two-photon 
emission is be ascribed to the large TPA cross section of PFVCN (large difference 
of TPA cross sections between PFVCN and  TPP) which makes it as an effective 
two-photon light harvesting materials as well as the two-photon excitation 





















































40 Bare TPP  NPs
Figure 6.4 (a) Two-photon excitation emission of bare PFVCN NPs and T-P NPs 
with different TPP doping concentration. (b) Two-photon excitation emission of 
bare TPP NPs with different TPP concentration. (c) Enhancement factor of two-
photon excitation emission of TPP from T-P NPs with difference TPP doping 
concentration. 
 
6.3.3  Enhanced singlet oxygen generation  
High singlet oxygen generation efficiency is required for the application of 
photosensitizers in PDT. Lipid micelles, silica and polymer nanoparticles have 
been utilized to encapsulate and delivery hydrophobic photosensitizers for PDT.28 
The nanoparticles retains good singlet oxygen generation ability under certain 
concentration in which self-quenching of photosensitizers limited. The singlet 
oxygen generation ability of TPP-doped PFVCN nanoparticles have been 
evaluated by monitoring the phosphorescence emission of singlet oxygen at ~1270 
nm in D2O. Figure 6.5a shows a typical example of the characteristic emission 
peak of singlet oxygen generated from 0.25TPP-doped PFVCN nanoparticles and 
bare TPP nanoparticles with same amount of TPP, under one-photon excitation. It 
apparently revealed that the emission was significantly enhanced for TPP doped 
nanopaticles compared to the bare TPP nanoparticles, which is ascribed to the 
amplified energy transfer from PFVCN to TPP subsequently followed by a series 
of photophysical processes to generate singlet oxygen. To study the relationship 
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for enhanced singlet oxygen ability with enhanced emission of TPP, the 
enhancement factors of singlet oxygen phosphorescence and TPP fluorescence 
emission of nanoparticles doped with different amount of TPP  were evaluated. As 
shown in Figure 6.5b shows that the enhanced factor for singlet oxygen 
generation ability shows good consistence with the enhancement factor for TPP 
emission, which indicated that the emission factor for TPP emission can be 
utilized to evaluate the enhanced singlet oxygen generation ability. 
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 Bare TPP NPs
(a) (b)
Figure 6.5 (a) singlet oxygen emission in presence of 0.25T-P NPs under 
maximum excitation wavelength at 469 nm and bare TPP NPs with same TPP 
concentration, under excitation under max. excitation wavelength at 416 nm. (b) 
Enhancement factor of singlet oxygen generation ability of T-P NPs and TPP 
emission of T-P NPs in difference TPP doping concentration. 
 
The ability of the nanoparticles to generate singlet oxygen under two-photon 
excitation at 810 nm was evaluated by monitoring the photo-oxidation of 9,10-
anthracenediyl-bis(methylene) dimalonic acid (ABDA).29  . As shown in Figure 
6.6 under the same experimental condiction, ABDA in presence of bare PFVCN 
NPs and bare TPP nanoparticles show no apparrent decrease after irradiation for 
180 min, indecating their defficient two-photon induced singlet oxyen generation. 
However, in presence of 0.25T-P NPs, ABDA amount decrease dramatically after 
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irradiation for 90 mins, indicating that the 0.25T-P NPs can efficiently generate 
singlet oxygen under two-photon excitation. The signigicant enhanced two-photon 
induced singlet oxygen ablity is ascribed to the dramatical enhancement of two-
photon properties of the nanophotosensitizers by two-photon induced amplified 
energy transfer from PFVCN to TPP, following by a series of photophysical 
processes to generate singlet oxygen. 
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Figure 6.6  Two-photon induced oxidation of ABDA in presence of bare TPP NPs, 
bare PFVCN NPs, and 0.25T-P NPs under excitation at 810 nm. 
 
6.3.4  Folate mediated uptaking of NPs 
Since the 0.25%T-P NPs have optimized two-photon induced singlet oxygen 
generation ability, the folate functionalized 0.25%T-P NPs (FA-T-P NPs) by 
replacing DSPE-PEG(2000) with DSPE-PEG(2000)-Foalte. These nanoparticles 
were demonstrated for trageted two-photon PDT in cell level. To evaluate that the 
folate-mediated targeting effect of the nanoparticles, we first compared the 
nanoparticle uptake in KB cancer cells (folate acceptor overexpressing)30,31 to 
normal NIH/3T3 cells (no folate acceptor overexpressing)32 by one-photon and 
two-photon excited fluorescence cell imaging. The folate functionalized 
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nanoparticles were incubated in KB cancer cells and NIT/3T3 cells for 6 hours. 









Figure 6.7 One-photon excited fluorescence images (left), merged images (middle) 
and two-photon excited fluorescence images (right) of (a) KB cancer cell 
incubated with FA-T-P NPs, (b) normal NIH/3T3 cells incubated with FA-T-P 
NPs, and (c) KB cancer cells incubated with 0.25T-P NPs. 
 
 
As shown in Figure 6.7, intensive fluorescence signal was observed in KB 
cancer cells, indicating FA-T-P NPs , but almost no fluorescence signal was 
detected in NIT/3T3 cells, indicating the FA-T-P NPs were specific uptaken by 
KB cancer cell, presumably as a result of the folate receptor-mediated uptake. The 
further verify the folate receptor mediated uptake of the nanoparticles, control 
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nanoparticle incorporating with DSPE-PEG(2000) which do not have folic acid 
were prepared. KB cancer cells were incubated with the control nanoparticles and 
cell imaging were carried out under the same condition.  As shown in Figure 6.8c 
no fluorescence signal was observed in the KB cancer cells. This result further 
confirmed that the effective uptaking of FATP NPs is mediated with the spesific 
trageting effect of surface folic acid with folate acceptors overexpressing in KB 
cancer cells.  
 
6.3.5 Folate mediated cancer cell targeted two-photon PDT 
The targeted PDT effect toward KB cancer cells over NIT/3T3 cells was 
investigated by the XTT assay. In these experiments, KB and NIH-3T3 cells were 
incubated with FA-T-P NPs (20 μM) for 12 h, followed by exposure to 
femtosecond laser irradiation at 810 nm with energy density of ~3.0 W·cm-2. The 
laser beam was unfocused with a beam size of ~0.3 cm2. As shown in Figure 6.8, 
there are no apparent cell death after irradiation over 15 min for NIT/3T3 cells 
incubated with FA-T-P NPs and KB cells incubated with PEG-T-P NPs, which are 
consistent with the imaging result that the nanopartcles are not efective uptaken by 
the cells due to lack of folate-mediated internalization effect. Control experiment 
shows no obvious two-photon PDT effect for KB cells incubated with FA-T NPs 
followed by two-photon irradiation under same condition, due to their lack of 
efficient two-photon induced singlet oxygen generation ability. However,  the 
viability of KB cells incubated with FA-T-P NPs significantly decreased to ~42% 
after irradiation over 15min, which is due to the specific uptaking of the 
nanoparticles into KB cells followed by effectively generation of singlet oxygen 
under two-photon excitation to caused cell death. The two-photon PDT effect for 
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KB cancer cells incubated with FA-T-P NPs were also evaluated by the direct 
bright field cell images. As shown in Figure 6.9,  the cell numbers decreases 
obviously after irradiation for 5 min to 15 min. Under same experimental 
condition, the number of KB cancer cells incubation without NPs show no 
obvious change after irradiation for 15 min. These results clearly suggest that our 
strategy to develop photosensitizer-doped conjugated polymer nanoparticles can 
be act as promising efficient two-photon nanophotosensitizers for potential cancer 
cell-targeted two-photon PDT applications.  
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Figure 6.8 Laser irradiation time dependent cell viability of KB cancer cells and 
normal NIH/3T3 cells treated with FA-T-P NPs, and KB cancer cells treated with 
0.25T-P NPs and FA-TPP NPs, after two-photon PDT treatment (irradiation by 
femtosecond laser pulses at 810 nm). 
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FA-T-P NPs, 0 min FA-T-P NPs, 5 min
FA-T-P NPs, 10 min FA-T-P NPs, 15 min
Control, 0 min Control, 15 min
 
Figure 6.9 Bright field cell image of KB cancer cells treated with FA-T-P NPs 
after irradiation of femtosencond laser at 810 nm for 0, 5, 10, and15 min. Control 
are KB cancer cells without treatment of FA-T-P NPs after irradiation of 
femtoseond lasers at 810 nm for 0 and 15 min. 
 
 
6.4  Conclusion 
In summary, we have demonstrated the development of high efficient conjugated 
polymer nanophotosensitizers by using a conjugated polymer with large TPA 
cross section PFVCN as two-photon light harvesting materials and energy donor 
and TPP as energy acceptor and photosensitzing molecule. The amplified energy 
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tansfer  from PFVCN to TPP have been studied. The prepared T-P NPs were 
found to display a significant enhancement up to 1000 folds of the two-photon 
emission of TPP, and efficient two-photon induced singlet oxygen generation 
ability. The optimized T-P NPs were futher functionalized with folate on the 
surface. One-photon and two-photon cell imaging show that the FA-T-P NPs 
shows highly specific targeting ability to folate acceptor overexpressing cancer 
cells. Moreover, the enhanced folate acceptor targeted two-photon photodynamic 
therapy effect on cancer cells have been demonstrated. These results suggest that 
conjugated polymer nanophotosesntizers can be act as promising high efficient 
two-photon  photosensitizers for cancer cell specific targeted two-photon PDT 
with improved cancer therapy effeciency and less harmness to normal tissue. 
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For biological imaging and therapy, high spatial resolution (3-dimensional 
selectivity) and deep tissue penetration are of great scientific and practical 
importance. Two-photon excitation imaging and PDT are promising noninvasive 
techniques for deep tissue imaging and cancer treatments with high spatial 
resolution. Conjugated polymers have received lots of attentions for biological 
applications due to their unique optical properties and good biocompatibility. The 
two-photon light harvesting properties of conjugated polymers also indicates their 
great promise in potential two-photon biological application. It would be of great 
scientific and practical importance to develop conjugated polymers for two-
photon biomedical applications. The main theme of this thesis is to synthesize and 
develop conjugated polymers for two-photon biomedical applications, especially 
for two-photon imaging and two-photon PDT application. The significant finding 
obtained in each step are outline in the following content. 
Firstly, we designed and synthesized two new water-soluble conjugated 
polymers, acting as two-photon light harvesting complexes to amplify the two-
photon property of water-soluble photosensitizers and organic dyes through 
fluorescence resonance energy transfer. Two new water-soluble conjugated 
polymers, PFE and PFV, have been designed and synthesized. The TPA cross 
sections at 800 nm have been significantly improved by inserting the vinylene and 
ethynylene groups as the bridges, which extend the conjugation length. The two-
photon excitation emission of the photosensitizer RB was found to be significantly 
enhanced through FRET by using these conjugated polymers as two-photon light 
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harvesting complexes. The inherent two-photon property of CCPs is believed to 
be the primary factor responsible for the observed huge enhancement in the two-
photon emission of the photosensitizer. These studies are expected to provide 
insight on designing systems with further improved performance for potential 
applications in two-photon PDT, sensing and imaging. 
Singlet oxygen is critical for two-photon PDT. To study the ability of 
conjugated polymer for enhancing two-photon excitation singlet oxygen 
generation ability, we then developed photosensitizer-doped conjugated polymer 
nanoparticles using PFEMO as hosting materials and TPP as energy acceptor have 
been prepared by using a re-precipitation method. Efficient intra-particle energy 
transfer from PFEMO to TPP has been observed. The two-photon emission of 
TPP was found to be significantly enhanced by up to 21 folds in the nanoparticles. 
The larger TPA cross section of conjugated polymers and efficient energy transfer 
from PFEMO to TPP helps to enhance the efficiency of singlet oxygen generation 
under two-photon excitation. The results suggest that these photosensitizer-doped 
conjugated polymer nanoparticles can act as novel photosensitizing agents for 
two-photon PDT and related applications. 
 Following that, we demonstrated biocompatible conjugated polymer 
nanoparticles for potential simultaneous two-photon imaging and two-photon PDT 
in cell level. The incorporation of polyoxyethylene short chains onto the 
nanoparticles’ surface ensures good stability for cellular applications. These 
nanoparticles have low cytotoxicity in dark and can be easily up-taken and 
internalized by HepG2 cancer cells. The enhanced two-photon photodynamic 
activity of the nanoparticles in living cancer cells has been demonstrated. In 
addition, these nano-photosensitizers allow simultaneous in-vivo monitoring 
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during the two-photon photodynamic treatments. Moreover, our results indicated 
that even higher PDT efficiency of photosensitizer doped conjugated polymer 
nanoparticles could be achieved by selecting conjugated polymers with even 
larger TPA cross sections and optimizing energy transfer efficiency between the 
polymers and photosensitizers.  
Base on the studies on two-photon optical properties of conjugated polymers, 
we further designed and synthesized two PFV type conjugated polymers with 
different substitute group on the backbone. By introducing strong electron 
withdrawing cyano group into phenyl ring of the backbone, PFVCN displayed 2.4 
time higher maximum two-photon absorption cross section per repeat unit and 
significantly higher fluorescence quantum yield (~20%) in water than the 
unsubstituted PFV. The TPA action cross section of PFVCN is 39 times higher 
than that of PFV at 810 nm. The large two-photon action cross section of PFVCN 
makes it a promising material for two-photon cell imaging. Moreover, PFVCN 
displayed high two-photon induced singlet oxygen generation activity due to its 
large TPA cross section and reasonable singlet oxygen generation yield, and was 
demonstrated for two-photon PDT on cancer cells. These studies suggest that 
water soluble conjugated polymers with large TPA cross sections can be 
developed as promising novel photosensitizing agents with dual capability of two-
photon imaging and two-photon PDT. 
Finally, we developed high efficient conjugated polymer nanophotosensitizers 
for cancer cell targeted two-photon PDT. The novel nanophotosensitizers were 
found to display a significant enhancement the two-photon emission (up to 1000 
folds) and efficient two-photon induced singlet oxygen generation ability. The 
folate functionalized nanophotosensitizers shows highly specific targeting ability 
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to folate acceptor overexpressing cancer cells. The enhanced folate acceptor 
targeted two-photon PDT effect on cancer cells have been demonstrated. These 
results suggest that the conjugated polymer nanophotosesntizers can be act as 
promising high efficient two-photon  photosensitizers for cancer cell specific 
targeted two-photon PDT with improved cancer therapy effeciency and less 
harmness to normal tissue. 
In this thesis, the design, the one-photon and two-photon optical properties and 
appliation of conjugated polymers for the purpose of optential two-photon 
imaging and two-photon PDT applications in cell level have been successfully 
studied. The thesis clearly demonstrates a general strategy to design and synthsize 
conjugated polymers with large TPA cross sections as light harvesting materials, a 
fundamental understanding of two-photon induce amplified energy transfer to 
improve singlet oxygen generation, and a guideline to develop high efficient 
conjugated polymer based two-photon photosenstizers with improved therapy 
efficiency for potential in vivo two-photon PDT application.  
